**SUSTAINABLE TECHNOLOGY ADOPTION SCORE: 72/100**

Technology Adoption: 18/25  
Innovation Leadership: 17/25  
Measurable Impact: 18/25  
Future Strategy: 12/15  
Industry Position: 7/10

Summary (brief): AbbVie has implemented a broad set of sustainable technologies (renewable electricity procurement and on‑site solar, cogeneration, wastewater reuse, EV fleet electrification, energy‑efficiency projects) and is scaling many of them through PPAs, CapEx funds and operational rollouts. The company is investing in innovation (mechanochemistry, “chemistry in water,” AI/ML-enabled manufacturing and analytics platforms, sustainability patents) and shows measurable progress (Scope 1 & 2 reductions >30%, renewable electricity >60% active sourcing in 2024, waste and water reductions). Compared with large pharma peers AbbVie ranks above average — active and improving, but not the sector’s outright leader on sustainable‑technology metrics. Key near‑term gaps are more granular project‑level disclosure (MWh / tCO2e per project), explicit Scope 3 reduction targets and faster timelines to match the fastest peers. (Details, evidence and scoring justification below.)

Findings and evidence by research area

Technology Adoption (what specific technologies; justification for 18/25)
- Renewable electricity procurement and PPAs: multiple corporate PPAs (including a 10‑year PPA with Invenergy for 100 MW from the Santa Rita East Wind Farm in Texas) to supply U.S. operations; several other wind/solar PPAs announced 2022–2024. These PPAs are material contributors to AbbVie’s electricity mix and emissions reductions ([corporate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGh8qe6dB8FgMHB6LxV-th1gy8FZ9F5jiNYUy4IUQR3ud7AG7OONmqdYUbeQ3QbOwQFWm3vlf9FDzrFjoJr-kiZJrdW4qIk7dFVqReMSLjqeJh2_nTktiIXoJrroJONkV190olB_j_jpg==), [mja](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtG39l1FI6DPVI68bQdMw0q9D4F44n24dbP2JTtbtelVdb0yu-3SBu6YWq1fGj6XY_9iskQ-IboqNaLmN-zq6aQ833lrGQsTb4zN7rKuTht7L5YU3xPbJh_0WqRdrVs6T8YpS4xDF8bjUmHZqTJpnKP-atsZv7XOYlAnNI181WhXdHRd6ylKyJ0jZcp2TLNBg8Wg==), [prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHArLQZroYRa7_J_dYFt8-VmB0OqJ3ZiIfGZCoUi_0cZQibyooIQ0LbqR8LOjDMP30dcs8DI0Xv8zA8hE1tXh8JK49FH1iVzO9vGawNOXNYm3DKjDoQhOyJ6_-9FuF5LHJY7Yz8TftT5vj-d_CDkhct-kVkVun09Fgq85AF5rA8KnnRgKHfmxQgqhkjRaIw99qAVS67QJuNhPT_WVsRrB65AlRKbzGSIw==)).  
- On‑site solar and installations: photovoltaic system at Liège (Belgium) providing ~1/3 of the site’s electricity and >4,000 panels in Puerto Rico producing ~1.5M kWh/year (2022+ projects) ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE8VNDjrlv2JYKMmx_vZpbR859sXNFBiekgj3-yvaLgVx3rOCNY8hUH-RNSSlbadR47m_1lFgV17CC-vrkztMSL3oNRaDAL8bu3aZa1RfaTMTxGjDvg8yMPgBIP77OdxnXBSH0Yn7eGAld5FjYx-1ZpuSRDOKzzWvrXKM7F3SSQvMRIANMVaa3fFeMZcBqbw06l-bXZlnibJ8UbO_eID7n5UGOP9yFC), [corporate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGh8qe6dB8FgMHB6LxV-th1gy8FZ9F5jiNYUy4IUQR3ud7AG7OONmqdYUbeQ3QbOwQFWm3vlf9FDzrFjoJr-kiZJrdW4qIk7dFVqReMSLjqeJh2_nTktiIXoJrroJONkV190olB_j_jpg==)).  
- Energy efficiency & CapEx fund: centralized CapEx / decarbonization funds allocated to dozens of projects (2024: ~$13M to 68 projects including heat recovery, LED lighting, VSDs, steam trap monitoring) and upgrades to equipment/HVAC across sites ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvwq8-hjjRhkRD3Pdk2h75QTEE0Ol4KLoblL3lAvlZkWT-RU_vVebJJsztQ5LW1yRJeI6aW2zV5b6dyHzHWCYSXZtGdNvWJVyVs9MQVDPcPlrlsxGQ8LtkmH0ltzd0qNUiMS6dU6TDbbYJia8RKOagU_vovjgQNkxXwn2p1QdVIa0drVYIYZicKCTi), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE8VNDjrlv2JYKMmx_vZpbR859sXNFBiekgj3-yvaLgVx3rOCNY8hUH-RNSSlbadR47m_1lFgV17CC-vrkztMSL3oNRaDAL8bu3aZa1RfaTMTxGjDvg8yMPgBIP77OdxnXBSH0Yn7eGAld5FjYx-1ZpuSRDOKzzWvrXKM7F3SSQvMRIANMVaa3fFeMZcBqbw06l-bXZlnibJ8UbO_eID7n5UGOP9yFC)).  
- Cogeneration (Barceloneta): on‑site cogeneration completed earlier and used for resilience and lower energy‑related CO2 at the Barceloneta plant; wastewater reverse osmosis and purification systems in Puerto Rico / other sites used for reuse and reduced freshwater demand ([newsismybusiness](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFSzHNYDNwXllNAYJrz68x5oQ5XAi9RpXEX917AVdeRFJ5cX7IiOviCAPNfQ04pTOlTkPCZz7m9-fIENHYAYL_55jRVq2kpIXT9tWzX6GMwMWvJwYSoL6P77myqDnJP-rJl0_HZN8jnZ8t5FxvdwkP7YK2XJOcVbjln3UTV-8wujeTC04ulFp1KChFYwBGAwYXfGzEIjtQdtrtqkQ==), [bandlondon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFoF2lzzMXn_EW5Q_mWBABxs1J-7ji0192wb3OW2tlnWJRv3vEX_S6VIj2IV-RV9GDu_FpqUwuuUSbHUGTeZudbtDoWtvJsAa1Jz0mljzH41LDPNNyJg6uvr9_zNas-HI4omf8P9eO1-OU0xSbidPtsZz53lx1xp1bqxRt_kdN78_2PhUNulrH8GQ==), [iu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGi24r99RbVk8rI6Bv-rlJwhFU3azV79a4O8VAtRKXBhGPAVPFEKrJGtKd8Q5BT3pzA4boGSBR3gVtKfnrXg8vwqwjPwhJG5JdxWbJ5o71FqPb1x_AQ1pGLaxB4MCGBMHWhTZkHNwOi0YVoJ99etxxtgrfwYImA2CRmlnZTAGe7Ku2V6ZGcwSjPeqDakYH7t4sjBHY-Ew72gzB8QAEdj1s=)).  
- Water & wastewater tech: pilot and commercial reverse osmosis / wastewater treatment at manufacturing sites (Singapore pilot → commercial system in 2024; reduced hazardous aqueous waste by >70% at that site) ([abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFYQTenVNwqHjChmcLEWN8edjt49Wgru71VxJXRXHsivrKhwZCRelOnXutw46eX_x3fCjRTW_7Xwpzdg1iJ3zWUhCWgQll8uzHLDLnxC2HoJtdTNeUkjDRXs1NT-MA5MLQ-8l9owbgCu3mEBfC-mvd9P0LR8yWZxYVsn2IkxRbV_Ul183r9W5RvHON-ffRz8=), [worldbenchmarkingalliance](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1nc-8IbydseMJPfqtKCvX_EIFb5DBqZCvrRUXiL195EdyyTyc7KTgLptb9AuCv1PFr_4_3gFH1p1CKLmzM0Spq05iYPmyjjLzurSuo5EbvA4HQaeebFObPo93r8U2Lyb31Vo-7LUVmsY8cvxhSSR57yRa-Bz07bQaKPO4usG6NVS548ksfvcY)).  
- Fleet electrification and EV charging infrastructure: >3,000 electric/hybrid vehicles by end‑2022 and ongoing rollout to EVs/PHEVs and chargers at facilities ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE8VNDjrlv2JYKMmx_vZpbR859sXNFBiekgj3-yvaLgVx3rOCNY8hUH-RNSSlbadR47m_1lFgV17CC-vrkztMSL3oNRaDAL8bu3aZa1RfaTMTxGjDvg8yMPgBIP77OdxnXBSH0Yn7eGAld5FjYx-1ZpuSRDOKzzWvrXKM7F3SSQvMRIANMVaa3fFeMZcBqbw06l-bXZlnibJ8UbO_eID7n5UGOP9yFC), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEXSDs3kV7G2BBCpx1420IMUmQzNpt-4iVjG1CBNAKvgdqHI3tKOFetkaSr1Nim7Em-r_OGqB_9I2ZoOkLChL2xUCf2qaN1VDWs6TH4OsWBXM_A-lgqDlqmjz6aBpry_zC500mE6yYRqbKKKZMEw9ktDVOt8DhXsR8WXn0SMM1bYLz3BoCFUZS1L1d2lOYDw7wrzaJuEwQ2Rk5jP2zgUI6Fq23Jox9raZqlBidAujLTulvECPBpeWM=)).  
- Sustainable chemistry/process innovations: work on mechanochemistry and “chemistry in water” to reduce solvent use and waste in synthesis ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEoNd8X8j7TviC6XtpHri4wG9ruSNtSzZwqqRrS0Qb4GpG8NTXt2tm0jz9Ky6cTScVGz6ST8k_XR3DvHdTq6M6upgmUW_SKIWmpMCQ-JMIMk3uMIolL30eu4Sp4zh1hBD9aCBqoZBESaLovZKtLTjmQBAtJlfItqSztAdoPgPtexpbf6GQgyvKFlv_j8jOZy_UOAOCXo9iljsONnnfeFfieIz41x6cPfS4Ed0r), [atomfair](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE2cM-xt5GopxR3kfPnZNSZGGZSdWgrmkbFsrn6IdT8gosqICS253fS0uHGZ01n1Amg7O5b5BIFThL902zjFf-MRUHdVXaazFw5urHalbxJUkP-jbE4D6ISGhJoTIx0SjMWQlQbQkRerPuJAwQ=)).  
- Digital/Factory of the Future: AI/ML (ARCH analytics hub, generative AI for proteins), robotics and analytics to optimize R&D and manufacturing, reducing material waste and cycle times ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHWctL4KLwhWLXFdEmsCvner426_ZT5IE5vrjErfSW2Vba-f5P9iJmbgD9EGH9w3OgXDNZqg8JCjG6U7ew5U0gTbSw7oghyAH_8Uf2-8mCXBTFDNnGEmPyqdgCMOmRjmqq8mViHQabgzvGKtNl5g1o6HKSYdm0W63hbAEV0-igS9XkysQ-pkfnkqpY=), [acumenstories](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHgR_PuyxPmWxors7Qpt0QR9qxivBJVd9k9LWnCvVuVbEtBjuNRlck11U8HQe8AAO24xGnoqCbCiFskUWz4La8cZhoKcX1VN2FINB-surqb13GstseHPFLmqqpoymSqwDtZoNs-23yStGaBrWQtMmcur_stZKlkGOoEVwE_UprWhVfeQKQrP7wJXyTHd3kKPJAil4KWGm5rBlLl0HrohhQkbJA87FLcCpU=), [youtube](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFGF3OntThaARCf32TLrhy62oeaTrFroR7ScfLjHVdGO8Lb3_stXtIELHoaO1PbqaDLvKkvH9llPJYVFqWstgg6HxOvRaB2tpRAMPEJbwhKQZxQ64zluUn8UOHJ2AFMZdbDXRssjCc=)).

Why 18/25: AbbVie has deployed several advanced and emerging sustainable technologies across manufacturing and operations and is using market instruments (PPAs) at scale, but many techs are mid‑scale pilots or site‑level deployments rather than company‑wide breakthrough transformations in every operation. Score reflects significant adoption with some remaining scaling to reach “multiple breakthrough technologies implemented at scale across all operations.”

Innovation Leadership (what R&D / partnerships; justification for 17/25)
- R&D and sustainable chemistry: active work on mechanochemistry and “chemistry in water” (Ludwigshafen & other labs) to eliminate organic solvents — a higher‑impact process innovation for pharma chemistry if scaled ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEoNd8X8j7TviC6XtpHri4wG9ruSNtSzZwqqRrS0Qb4GpG8NTXt2tm0jz9Ky6cTScVGz6ST8k_XR3DvHdTq6M6upgmUW_SKIWmpMCQ-JMIMk3uMIolL30eu4Sp4zh1hBD9aCBqoZBESaLovZKtLTjmQBAtJlfItqSztAdoPgPtexpbf6GQgyvKFlv_j8jOZy_UOAOCXo9iljsONnnfeFfieIz41x6cPfS4Ed0r), [atomfair](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE2cM-xt5GopxR3kfPnZNSZGGZSdWgrmkbFsrn6IdT8gosqICS253fS0uHGZ01n1Amg7O5b5BIFThL902zjFf-MRUHdVXaazFw5urHalbxJUkP-jbE4D6ISGhJoTIx0SjMWQlQbQkRerPuJAwQ=), [researchgate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHa_P_NzzHTZLeHnFsEB8CIXHhOVG2zcY9yCo3mYxA1rejnGcpHYKpt7CuO759DF7NTuxHScd78ZuQ4E3KH3-83eMb4LchszcBrO3rkmoyAJYc--PtY0hv6tNus3sRTTmz9ZtsjhBBkqo88uchQg4ALdAw3ciOCP8VWvWh_bplqxx7Q7IS41p2cE9mHS3ArJPhEr0xgHtcshnw1a_mRP_P7rvQTUO99GXg9ZgHUm3JYo9UZKgGhpNg7aGUWffpYcg-PSOQoqCq_l36Xn-5kwX0CAbw-6PYH5-8eHhjZ6M8=)).  
- AI / analytics platforms: AbbVie R&D Convergence Hub (ARCH) centralizes data and applies AI/ML (including generative AI for protein design) to speed discovery and optimize processes — this also supports manufacturing efficiency and reduced material use ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHWctL4KLwhWLXFdEmsCvner426_ZT5IE5vrjErfSW2Vba-f5P9iJmbgD9EGH9w3OgXDNZqg8JCjG6U7ew5U0gTbSw7oghyAH_8Uf2-8mCXBTFDNnGEmPyqdgCMOmRjmqq8mViHQabgzvGKtNl5g1o6HKSYdm0W63hbAEV0-igS9XkysQ-pkfnkqpY=), [aiexpert](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEX9ZlXb3NEVxMNw3DoSNz9W8DVOAR-d_dLW2k368gmxsLY-s6u0QWIkgonwaGLO3oftfeV5SEw8VolAClxhrKUGpnzuqXVbPripVYhHSgm_WiOvI2yvaPNjy_eUOCd4ToxCqIF14C9FNCS4ZhSyFlFV6zq86HsHplpvkaFFr1BGSQS7g9l95V6iRkqERSpG9QX)).  
- Internal innovation programs: Spark Innovation Accelerator to surface employee sustainability ideas and pilot them to implementation ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEoNd8X8j7TviC6XtpHri4wG9ruSNtSzZwqqRrS0Qb4GpG8NTXt2tm0jz9Ky6cTScVGz6ST8k_XR3DvHdTq6M6upgmUW_SKIWmpMCQ-JMIMk3uMIolL30eu4Sp4zh1hBD9aCBqoZBESaLovZKtLTjmQBAtJlfItqSztAdoPgPtexpbf6GQgyvKFlv_j8jOZy_UOAOCXo9iljsONnnfeFfieIz41x6cPfS4Ed0r)).  
- Partnerships & patents: collaborations with tech partners (e.g., Intel) and membership in industry green chemistry initiatives; AbbVie reported environmental sustainability patent activity (≈15 filings in Q3 2024) indicating proprietary work in this area ([aiexpert](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEX9ZlXb3NEVxMNw3DoSNz9W8DVOAR-d_dLW2k368gmxsLY-s6u0QWIkgonwaGLO3oftfeV5SEw8VolAClxhrKUGpnzuqXVbPripVYhHSgm_WiOvI2yvaPNjy_eUOCd4ToxCqIF14C9FNCS4ZhSyFlFV6zq86HsHplpvkaFFr1BGSQS7g9l95V6iRkqERSpG9QX), [pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHw-K8rvpgYTONbSPZLZjNHzeZOb6JreY8YqelXzowZ11XjDBNbNt28ZkCEU0IezPIkeyKbebo0F4cnCXImUSa2MHmr3LbnEV4NlMFhzXkd50x_dhOY6rK6EwyZI1Xu8-aJySTA2_JoAMymwzEAN-mWv4zbz3ceOWL31rICtBELVGDlJTorPlD1tnyTMsgPM6LhQ_dETlFHa_r0TtOYgNJF2nBhlq1XzIGa0aKPyKFvELZJaHkzY4c=), [industryintel](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8I8QezCJU-tvL6Il9ofCpXEqqGf9Ig020ie2V2CPXG_3kJaOEpsSGx90uUCoGIUn8JEGM1LWxfG6cjjRdX3x08MxqTZubi8gQfgcnpzOwE_qatACoOUxMorvt3_bM22fP6rra-avT-hSmEfwfHUZADlBbjguEQvhsV8P-iC6DTadlGtB-N7M7fqJTPwJg3sxlPxFLf3ZwuIrEFKopKHA2KO9VayK7wmUJONFiK5B51e9u0BVx2whwdXAyjorwx9nhb9PqaTrVV7o9DOS8infFaiUEbCoJfzK3lNQZiQ5Q_ycAL1jEuhgGwVjogXBgRWtBo3rwOQTQ3g3k25WJKaq-lk5VdCJr_XPz41MJ1pAmRX5pYy0vN6Dv2wSqBEXsNNMyezlRXv9GyYmdKCCFx6MHhnh2eDTOesaEBQ03PjfALm1VhqCp6hSUYhU=)).  
- Investment scale: large R&D spend overall (company R&D >$7B in 2022; multi‑$100M facility investments including a $195M North Chicago API expansion announced 2024/25) shows ability to invest in both product and process innovation ([responsibilityreports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHawZaCkB72r0MVbMV_jcF-7BQ6_IoWxbgzl0t_QcVNXT4emOt8sJE0GG8WguNj8-TKg0bp6_ikvXepo7tH_2sovhEQfMd73BXaCdba5-7bnxiOuRInP66hP0ugEhaPN0Wxk9oeZqQ16jEz0OdtyJCQJMfY298i8Q_XN3OuhQ2qy0GjBCM1LgfSFr5jJY9IviZuGPHlqQblS9GEWSs=), [pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGubfe-j4sIaJHtd13Yj_Gd3O-ItwREMQOu-wb_XcoT-nH4qOrwZRvVxYBa-pwiJH3QFN_ujvrMuV98Cyu55_yEvGBaQ-eLNf00aB3JoM3IrpFCf0Y_HahHQeF77RlBBGKesLpgv_Oyvn9YIe1vEwjQv7xKoopPiG6ecbBpcUV9pXqTEOdXCu2iqx3CHMTf), [prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFYbrEcV-jqiR1JqLYQvRUX90uRaXWByGnU9_cl6RxPuaPGsZlDVYfwcMKGZh6t86dCRFp-PHxEAmx4TqVCI4qwGs3IAZS6bW1PQOWnNXKv3Wrd1lO6viPlfuAGUe7RcQot_ggtS88T_hIxEqypNxmPOqTArbqZ2yTKawnLg1gbjfT675nW09NlAPkPDDua4FHilo2cuLSQYC_2ufFIhWN1NqTY1kmGjIluS8BFIIJFwvsMRhS7oO9lRYto7Y67RZQnW4tybHqGHis0X1ceHavwOd1vN2GfJMBqwEVRung=)).

Why 17/25: AbbVie demonstrates active proprietary and partnered innovation in sustainable chemistry, digitalization, and has patent filings and structured programs. It is strong in applied R&D integration (AI + process chemistry), but is not yet widely viewed as the single industry leader in sustainable‑technology R&D (some peers have faster timelines/ambitious SBTi‑validated Scope 3 plans). Score reflects a strong, maturing innovation program with notable proprietary activity and partnerships.

Measurable Impact (what quantified outcomes; justification for 18/25)
- Scope 1 & 2 reductions: AbbVie reports >32% reduction in Scope 1 & 2 GHG emissions vs 2021 (2024) and absolute Scope 1 = ~300,072,000 kg CO2e and Scope 2 = ~122,287,000 kg CO2e reported for 2024 — down from prior years ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqYnUN2uOUpjSU2IgJ7JZbysQSrpk2FA0KSlyQsugvlB5zLrVpM0qUCMua_ujp5-GSZD32STcESi0JBJajsl87qIpteQ-DCWYkzfch2DIWF6pnNbREYntPexaxlVCIqdzBYZsmpL_8VXpS1QAHLK--2HYsG7qln-J9IaEr4bABKP7Wef-1ogpIS_UK), [ditchcarbon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH2tLwERcPahTaB_djAmYp7zdQ-jRzTDrNpp1MAarE2Jo0P3cgbfeOjgS8HtwSsT-nkDJyAtpRHnF_yZWBtDC9kC33LDv_uZkcL7NVdwP0zU9zV1e7qQpC6So-dWq5hCSl_QF41EZS5), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvwq8-hjjRhkRD3Pdk2h75QTEE0Ol4KLoblL3lAvlZkWT-RU_vVebJJsztQ5LW1yRJeI6aW2zV5b6dyHzHWCYSXZtGdNvWJVyVs9MQVDPcPlrlsxGQ8LtkmH0ltzd0qNUiMS6dU6TDbbYJia8RKOagU_vovjgQNkxXwn2p1QdVIa0drVYIYZicKCTi)). This progress is material (falls in the 25–50% improvement band).  
- Renewable electricity increase: active sourcing of renewable electricity increased to >60% by 2024 (from ~30%–50% earlier), with PPAs contributing to major reductions (Invenergy PPA estimated to avoid >150,000 tCO2e/year) ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfOJcmwagDtRCWMEOJHPxXxBO_yVPhPtW5jm5qyqJJnGauD-sJC6vt90vxFfUIQQcfVjznwxG0s6AbnPXcQw3tHlkoPU9gn_h21d30L6m9w9eK42CA3EkiCE6LE2x9RJSm), [corporate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGh8qe6dB8FgMHB6LxV-th1gy8FZ9F5jiNYUy4IUQR3ud7AG7OONmqdYUbeQ3QbOwQFWm3vlf9FDzrFjoJr-kiZJrdW4qIk7dFVqReMSLjqeJh2_nTktiIXoJrroJONkV190olB_j_jpg==)).  
- Waste and water: achieved a 21.7% reduction in total hazardous+non‑hazardous waste (2015→2024), and ~16.9–20% reduction in absolute water withdrawal over 2015→2024 — close to 2025 targets ([abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGgiFpBqPOtaDr0qZ41nUL2AAhYkAsTCxfuG9XVq8tMGmpj7XGTmsQzyWq3S5ButB-0x7FF9RlKIjKflm6fX3aiJCZzl0NAIn6igYLpEoVPo48DwcgRFvQEkPHCvFdmruW4ct7nzcnN1GuRZgybUERMLh_8AkwBnfKSnBMwMcO8wd-s9FP3NVbHXljLAariQrYE), [abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFYQTenVNwqHjChmcLEWN8edjt49Wgru71VxJXRXHsivrKhwZCRelOnXutw46eX_x3fCjRTW_7Xwpzdg1iJ3zWUhCWgQll8uzHLDLnxC2HoJtdTNeUkjDRXs1NT-MA5MLQ-8l9owbgCu3mEBfC-mvd9P0LR8yWZxYVsn2IkxRbV_Ul183r9W5RvHON-ffRz8=)). Singapore wastewater pilot reduced hazardous aqueous waste by >70% at that site after commercial unit deployment ([abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFYQTenVNwqHjChmcLEWN8edjt49Wgru71VxJXRXHsivrKhwZCRelOnXutw46eX_x3fCjRTW_7Xwpzdg1iJ3zWUhCWgQll8uzHLDLnxC2HoJtdTNeUkjDRXs1NT-MA5MLQ-8l9owbgCu3mEBfC-mvd9P0LR8yWZxYVsn2IkxRbV_Ul183r9W5RvHON-ffRz8=), [worldbenchmarkingalliance](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1nc-8IbydseMJPfqtKCvX_EIFb5DBqZCvrRUXiL195EdyyTyc7KTgLptb9AuCv1PFr_4_3gFH1p1CKLmzM0Spq05iYPmyjjLzurSuo5EbvA4HQaeebFObPo93r8U2Lyb31Vo-7LUVmsY8cvxhSSR57yRa-Bz07bQaKPO4usG6NVS548ksfvcY)).  
- Energy efficiency savings: energy projects since 2021 have driven a ~4.5% GHG reduction; projected energy efficiency reductions of up to 7% by 2030 from CapEx programs ([abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFYQTenVNwqHjChmcLEWN8edjt49Wgru71VxJXRXHsivrKhwZCRelOnXutw46eX_x3fCjRTW_7Xwpzdg1iJ3zWUhCWgQll8uzHLDLnxC2HoJtdTNeUkjDRXs1NT-MA5MLQ-8l9owbgCu3mEBfC-mvd9P0LR8yWZxYVsn2IkxRbV_Ul183r9W5RvHON-ffRz8=), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEs5Zzondot3_horhn8YxqNqQrgrRy6NVFg5gtCGzFSl-WGk61Ww6A6R1P2J5pj7s2XtZXJSnUw9-bwYhtdBD6UUWodMIq88Wq4JjWbMyxtIeOH8oY5qukG_YDTMAAqUDm1DSAn0z0_EVneY3kLP1aJMMH80UruMBlKJD4vjP_f-Y5WGOaqVAVV2hsDepaCH09Q)).

Why 18/25: AbbVie reports clear, verifiable mid‑to‑large improvements in key KPIs (Scope 1 & 2 >32% vs 2021, renewable electricity >60%, waste and water reductions). These are significant (25–50% band for some metrics) but do not reach the >50% transformational improvements across all metrics required for the top score, and project‑level MWh / tCO2e figures are sometimes missing or not fully disclosed for all initiatives.

Future Strategy (commitments & roadmap; justification for 12/15)
- Targets and timelines: SBTi‑validated near‑term targets (reduce absolute Scope 1 & 2 emissions 42% by 2030 vs 2021), commitment to 100% renewable electricity by 2030, net‑zero emissions by 2050 (stated; some sources note ambitions toward 2040 for broader scopes), water halving by 2035, zero waste to landfill by 2035, and supplier engagement targets (79.1% of supplier emissions covered by SBTi by 2027) ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqcYfLroCIlX9rLkFtQqnc8QAyAD6zoCxnig7gLeJs5hax6O_k8O496d92xfB5_lyistz1hjI5nd_b9URQ_KQvekkhWKZjdKKM6IF9Skv3vkRrIivlxIpJZJwphp1A85xFz8lrGN63TRP8L_s_6ZvwiClWSW5zePSJuEhGwfVyA0efMkdAt0Yy5uDpego=), [net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEETLVwl2jen1tiPQFDk4H8EgyeUZscNS70J5fqsntRsdjpvaCSGZxf8s6EZI4kJn9hHO3M3d6cFCDmbkkGrmRKUsN9UZdB8Qhx-ODNmyIS640irCLpBQDzs6KjAGO0Vpsu4SJpGtSksmK1fEy4o7ujTQ==), [abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2pnoKBVxZd7Y1o2fZ0o7LTpqDQcP72LzXpwU48VGBdclCA5xEPnoy88WNluHfKu_ubXBEqTuSVzt0NkzOkocr1ULoEiOGlxA8i7RgAjCjOsievHzKRltJWDaUHoA1lEjuxsS8BrdW2F05Op8EHUdx0502fJau_-xhqtP-LfKmJqXEZjbJrwvEgtELxMsX9Bst)).  
- Governance & reporting: Board/Public Policy & Sustainability Committee oversight, an ESG Council and published annual ESG Action Reports and double materiality assessment in 2024 to guide disclosures ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqYnUN2uOUpjSU2IgJ7JZbysQSrpk2FA0KSlyQsugvlB5zLrVpM0qUCMua_ujp5-GSZD32STcESi0JBJajsl87qIpteQ-DCWYkzfch2DIWF6pnNbREYntPexaxlVCIqdzBYZsmpL_8VXpS1QAHLK--2HYsG7qln-J9IaEr4bABKP7Wef-1ogpIS_UK), [responsibilityreports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHK9SvrYsd5zKUvnJNYePMGi2AkUATctgoex-VE6FLa69IIJCSP7hcukFC-OR-rUXedFgQEcsIbndtgDH9HaZmX39GjMLOOWxlk97K4gzysTOxy7lI4aX4HkmhYxU7ysY1iL78BELUpTkKo0g9rX4i9j6z99WUZ6BO56dAzkmSMJOwGO0UAA99kDfoCjb8oq2qZHmOTtMWuF-sHsTk=)).  
- Funding & roadmaps: centralized CapEx / decarbonization funds, targeted project spending (e.g., $13M to 68 projects in 2024) and large manufacturing investments with sustainability components (North Chicago API expansion, part of larger U.S. investment plans) ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvwq8-hjjRhkRD3Pdk2h75QTEE0Ol4KLoblL3lAvlZkWT-RU_vVebJJsztQ5LW1yRJeI6aW2zV5b6dyHzHWCYSXZtGdNvWJVyVs9MQVDPcPlrlsxGQ8LtkmH0ltzd0qNUiMS6dU6TDbbYJia8RKOagU_vovjgQNkxXwn2p1QdVIa0drVYIYZicKCTi), [prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFYbrEcV-jqiR1JqLYQvRUX90uRaXWByGnU9_cl6RxPuaPGsZlDVYfwcMKGZh6t86dCRFp-PHxEAmx4TqVCI4qwGs3IAZS6bW1PQOWnNXKv3Wrd1lO6viPlfuAGUe7RcQot_ggtS88T_hIxEqypNxmPOqTArbqZ2yTKawnLg1gbjfT675nW09NlAPkPDDua4FHilo2cuLSQYC_2ufFIhWN1NqTY1kmGjIluS8BFIIJFwvsMRhS7oO9lRYto7Y67RZQnW4tybHqGHis0X1ceHavwOd1vN2GfJMBqwEVRung=), [pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGubfe-j4sIaJHtd13Yj_Gd3O-ItwREMQOu-wb_XcoT-nH4qOrwZRvVxYBa-pwiJH3QFN_ujvrMuV98Cyu55_yEvGBaQ-eLNf00aB3JoM3IrpFCf0Y_HahHQeF77RlBBGKesLpgv_Oyvn9YIe1vEwjQv7xKoopPiG6ecbBpcUV9pXqTEOdXCu2iqx3CHMTf)).  
- Gaps: while near‑term Scope 1 & 2 targets and renewable electricity goals are explicit, AbbVie has less public specificity and progress reporting on a time‑bound Scope 3 reduction pathway (some supplier targets exist, but a full Scope 3 roadmap / interim % reductions is less visible) ([worldbenchmarkingalliance](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1nc-8IbydseMJPfqtKCvX_EIFb5DBqZCvrRUXiL195EdyyTyc7KTgLptb9AuCv1PFr_4_3gFH1p1CKLmzM0Spq05iYPmyjjLzurSuo5EbvA4HQaeebFObPo93r8U2Lyb31Vo-7LUVmsY8cvxhSSR57yRa-Bz07bQaKPO4usG6NVS548ksfvcY), [ditchcarbon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFp9b__RlvvBJfAQEZUqUCmr06x8fIzUXfj2e5W11zRJwS3rrbCYZD8DERNfO99gh2zZLe3lvqqgX2paHRrZQvwxPXEuKKWh0jvoprCD6LYXJu8tZDB7qzqXz6pUnrJ_fdeZJKMYLk=)).

Why 12/15: AbbVie has a clear, resourced roadmap with validated near‑term targets, governance, and funding. It loses top marks only because Scope 3 strategy and some project‑level capital commitments against the 2030 roadmap are not as fully transparent/time‑bounded as the highest‑scoring examples.

Industry Position (comparison to peers; justification for 7/10)
- Where AbbVie stands: strong progress on Scope 1 & 2 reductions and renewable electricity procurement; recognized in indices/awards (e.g., Dow Jones Sustainability Index inclusion historically and Green Awards recognition) ([prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE_eE9yep0nDlmDgOsJLa-zKbF5_iWoxYk2I-e9PtQ_MjFlj4tOXR-o9xG0HKvSfmhGiCs2Hs_wJ-LLQu1ivfHqxzyVW94WZupLc5mYOIr_e38xRr6sd2v4pHGzfr0oZGaPJa3I_7zK9yeXqGLCdF-UY1q44fOqxTO8dkIsnrF4QE79kGZImAn83pTVq8AOFYTeqRRKfylyXvU24LsYm3bez-EJcO_cQXsO-a9FgM99x-C7qX88CDRc7E5ixqaj6Q==), [greenawards](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG-7F1U2-_VCvo6lrSc7_o9ledh71ELMLS9p84GL7KNfDV7heRdYNeZFDzuoKYODqOVKp4ALK-yMh-_6T2DdwMPHIPTXnN5bTHEIXVTghdxVMNSdbBeHKF4r030k3PLo3XoGwNEq5fijdNOqmi62SxOZaham8D0DtWQ1RR5CxlJVuF3Q5A3wwibyLvFOpYAeDvvNSO9AL1EbqdeGpjBK2aC8haOsZAn)). AbbVie’s mix of PPAs, on‑site installations and efficiency programs places it above average among large pharma companies.  
- Peer context: peers such as Novartis, Roche and J&J have set highly aggressive or earlier deadlines for 100% renewable electricity and/or net‑zero (e.g., Novartis targeted 100% renewable electricity by 2025; Roche and others have aggressive value‑chain targets validated by SBTi) and some have already achieved very high renewable percentages in operations ([novartis](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEldleJvCx3Cf679ezUqP4mZiFAyAGN0WBZHyRNi9mbB_MZQz58iPN-An8quOCjZAbBqIjCNWSqX3YvoA4zQlJBDSSA4dwcfHl2J-ii7sPQ5r_lptV8YSjmo3HuLvAgO197GPJeOJllt3MQpeoI-h0_gJf1MLB2VNolFvju9ShaTgvw40nb-_PrX87_kr21FebDVZGNL9E=), [roche](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWv5JlZHJBotqesVxWch0GMHTilMNUUSXurmdBYqxlV6IqKLO3BhJ4lTmQLG4Em2UsyTb0PJkwWWgW2IKmvxhAbAcGdkvDU9a6KEoRHVld5eeXb1OPiy6k53Ee4Q06s2R7m4L1tNBlb7vpZZIYjmiBNyZqiuB44XuPAQEvGQ==), [jnj](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF6EJOwIjtwR0J4tsIwR_wahVWMNOJCl08I0EK-5jxfLm_kfPGapgUwPq69rWuPZ1UNUBXih_VjEly-pgr0KuJUu2oDuhIP8H1P0RGFT9SLC2vV0NtKiOvX_xJnXBKtqtwHZ3_H-ygAXa2EgNwKkngSu2If8iyJn69oZpOiU5FMKHJ0CYyP94wAPA2glEhn8D5IGWhYPuW8IH716cLkmmtndzG0SZs=)). AbbVie is competitive but not clearly #1.  
- Supplier/scope‑3: many leading peers have more advanced Scope 3 commitments and values (some set earlier net‑zero across value chains); AbbVie’s supplier target (79.1% by 2027) is strong but progress to date is partial ([net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFOeou_7NWvlUcU-6LvQlDjkU7hiE6QVl7pmRs-IuTpsd39uzmoYQ7_mczvKcsje3RAsPYsJy5T6O5Qx_2PpFLVurfkzzpmR5F9C0VKwMZBP6QhMn3h2k228mU1P1XWAgWxtpKaZht7PpVQGQVl_a8LmQ==), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFhjuBZ8WyO2kagE-yN1P6GjayLrSaaph5o7cxKqiTRBAf1B3v-pb4fReXU62brZiCAtROOCKGGsxRe_7KHNIyLNxHlbLAI0X4J94yhY3H6ai-cdoKbPBa6Iaz7Girpc6xFt-inOSUgsXaKuR69ipjr0RKGHZTXQosY3D7UR_jjcl3oBy51tzb4PH0ZmwjsntKsFVCR1JthGsDMXx56ExBe42WXDzgp), [irishtimes](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFTuaqZpa727v1RyDYZ4xayNi8w2iBkez7WLjqkn-BOmdW31YxA9lTJgBEjvGQiDlaVNvs601G6F6GeUHyvvD8rtbBGakQHH8AABhJJN0OhoceIr3luR7AFpipPdHnB4nG9UkcGcSqBjj9dzRN13oD6fOwkntECil9gVWmFYly5novt12D5lrxjPce9TJ_ndeYwlCfJaEeDbdb45ao3Iggqn3fWCO4217VakEYlUyDn-9YchqncEmH5Vc8NRA==)).

Why 7/10: AbbVie is among the stronger performers in pharma for sustainable technology deployment and procurement, but a few peers are ahead on timelines and Scope 3/value‑chain ambition — placing AbbVie in the “among top performers” / upper‑mid tier, not the single sector leader.

Representative recent examples (2022–2025)
- 2022: Liège PV installation (supplies ~1/3 of site electricity) and Puerto Rico ~4,000 solar panels (~1.5M kWh/yr) deployments; Irish operations reached 100% renewable electricity in some sites by end‑2022 ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE8VNDjrlv2JYKMmx_vZpbR859sXNFBiekgj3-yvaLgVx3rOCNY8hUH-RNSSlbadR47m_1lFgV17CC-vrkztMSL3oNRaDAL8bu3aZa1RfaTMTxGjDvg8yMPgBIP77OdxnXBSH0Yn7eGAld5FjYx-1ZpuSRDOKzzWvrXKM7F3SSQvMRIANMVaa3fFeMZcBqbw06l-bXZlnibJ8UbO_eID7n5UGOP9yFC), [irishtimes](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFTuaqZpa727v1RyDYZ4xayNi8w2iBkez7WLjqkn-BOmdW31YxA9lTJgBEjvGQiDlaVNvs601G6F6GeUHyvvD8rtbBGakQHH8AABhJJN0OhoceIr3luR7AFpipPdHnB4nG9UkcGcSqBjj9dzRN13oD6fOwkntECil9gVWmFYly5novt12D5lrxjPce9TJ_ndeYwlCfJaEeDbdb45ao3Iggqn3fWCO4217VakEYlUyDn-9YchqncEmH5Vc8NRA==)).  
- 2023–2024: SBTi validated near‑term targets; reported >32% reduction in Scope 1 & 2 vs 2021; active renewable sourcing >60% (2024) ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqYnUN2uOUpjSU2IgJ7JZbysQSrpk2FA0KSlyQsugvlB5zLrVpM0qUCMua_ujp5-GSZD32STcESi0JBJajsl87qIpteQ-DCWYkzfch2DIWF6pnNbREYntPexaxlVCIqdzBYZsmpL_8VXpS1QAHLK--2HYsG7qln-J9IaEr4bABKP7Wef-1ogpIS_UK), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfOJcmwagDtRCWMEOJHPxXxBO_yVPhPtW5jm5qyqJJnGauD-sJC6vt90vxFfUIQQcfVjznwxG0s6AbnPXcQw3tHlkoPU9gn_h21d30L6m9w9eK42CA3EkiCE6LE2x9RJSm)).  
- 2024: $13M allocated to 68 energy/water/waste projects; Singapore wastewater pilot moved to a commercial unit with >70% hazardous aqueous waste reduction at that site; AbbVie exceeded its 2015–2025 waste reduction goal (21.7% reduction) ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvwq8-hjjRhkRD3Pdk2h75QTEE0Ol4KLoblL3lAvlZkWT-RU_vVebJJsztQ5LW1yRJeI6aW2zV5b6dyHzHWCYSXZtGdNvWJVyVs9MQVDPcPlrlsxGQ8LtkmH0ltzd0qNUiMS6dU6TDbbYJia8RKOagU_vovjgQNkxXwn2p1QdVIa0drVYIYZicKCTi), [abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFYQTenVNwqHjChmcLEWN8edjt49Wgru71VxJXRXHsivrKhwZCRelOnXutw46eX_x3fCjRTW_7Xwpzdg1iJ3zWUhCWgQll8uzHLDLnxC2HoJtdTNeUkjDRXs1NT-MA5MLQ-8l9owbgCu3mEBfC-mvd9P0LR8yWZxYVsn2IkxRbV_Ul183r9W5RvHON-ffRz8=), [abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGgiFpBqPOtaDr0qZ41nUL2AAhYkAsTCxfuG9XVq8tMGmpj7XGTmsQzyWq3S5ButB-0x7FF9RlKIjKflm6fX3aiJCZzl0NAIn6igYLpEoVPo48DwcgRFvQEkPHCvFdmruW4ct7nzcnN1GuRZgybUERMLh_8AkwBnfKSnBMwMcO8wd-s9FP3NVbHXljLAariQrYE)).  
- 2024–2025: Recognition as Green Large Organisation of the Year (Green Awards 2025) and continued PPA announcements including Invenergy (100 MW wind PPA) estimated to avoid >150k tCO2e/yr for U.S. operations ([greenawards](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG-7F1U2-_VCvo6lrSc7_o9ledh71ELMLS9p84GL7KNfDV7heRdYNeZFDzuoKYODqOVKp4ALK-yMh-_6T2DdwMPHIPTXnN5bTHEIXVTghdxVMNSdbBeHKF4r030k3PLo3XoGwNEq5fijdNOqmi62SxOZaham8D0DtWQ1RR5CxlJVuF3Q5A3wwibyLvFOpYAeDvvNSO9AL1EbqdeGpjBK2aC8haOsZAn), [corporate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGh8qe6dB8FgMHB6LxV-th1gy8FZ9F5jiNYUy4IUQR3ud7AG7OONmqdYUbeQ3QbOwQFWm3vlf9FDzrFjoJr-kiZJrdW4qIk7dFVqReMSLjqeJh2_nTktiIXoJrroJONkV190olB_j_jpg==)).

Key strengths and risks (brief)
- Strengths: credible SBTi‑validated targets; measurable Scope 1 & 2 progress; concrete renewable procurement (PPAs + on‑site solar); targeted CapEx and project funding; sustainable chemistry R&D and AI/ML to reduce process footprints ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqcYfLroCIlX9rLkFtQqnc8QAyAD6zoCxnig7gLeJs5hax6O_k8O496d92xfB5_lyistz1hjI5nd_b9URQ_KQvekkhWKZjdKKM6IF9Skv3vkRrIivlxIpJZJwphp1A85xFz8lrGN63TRP8L_s_6ZvwiClWSW5zePSJuEhGwfVyA0efMkdAt0Yy5uDpego=), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEoNd8X8j7TviC6XtpHri4wG9ruSNtSzZwqqRrS0Qb4GpG8NTXt2tm0jz9Ky6cTScVGz6ST8k_XR3DvHdTq6M6upgmUW_SKIWmpMCQ-JMIMk3uMIolL30eu4Sp4zh1hBD9aCBqoZBESaLovZKtLTjmQBAtJlfItqSztAdoPgPtexpbf6GQgyvKFlv_j8jOZy_UOAOCXo9iljsONnnfeFfieIz41x6cPfS4Ed0r), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHWctL4KLwhWLXFdEmsCvner426_ZT5IE5vrjErfSW2Vba-f5P9iJmbgD9EGH9w3OgXDNZqg8JCjG6U7ew5U0gTbSw7oghyAH_8Uf2-8mCXBTFDNnGEmPyqdgCMOmRjmqq8mViHQabgzvGKtNl5g1o6HKSYdm0W63hbAEV0-igS9XkysQ-pkfnkqpY=)).  
- Risks / gaps: limited public, consistent project‑level MWh/tCO2e savings for many initiatives (makes attribution and benchmarking harder); Scope 3 full reduction pathway less explicit; some peer companies have earlier deadlines for 100% renewable electricity or broader value‑chain net‑zero targets ([worldbenchmarkingalliance](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1nc-8IbydseMJPfqtKCvX_EIFb5DBqZCvrRUXiL195EdyyTyc7KTgLptb9AuCv1PFr_4_3gFH1p1CKLmzM0Spq05iYPmyjjLzurSuo5EbvA4HQaeebFObPo93r8U2Lyb31Vo-7LUVmsY8cvxhSSR57yRa-Bz07bQaKPO4usG6NVS548ksfvcY), [novartis](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEldleJvCx3Cf679ezUqP4mZiFAyAGN0WBZHyRNi9mbB_MZQz58iPN-An8quOCjZAbBqIjCNWSqX3YvoA4zQlJBDSSA4dwcfHl2J-ii7sPQ5r_lptV8YSjmo3HuLvAgO197GPJeOJllt3MQpeoI-h0_gJf1MLB2VNolFvju9ShaTgvw40nb-_PrX87_kr21FebDVZGNL9E=), [roche](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWv5JlZHJBotqesVxWch0GMHTilMNUUSXurmdBYqxlV6IqKLO3BhJ4lTmQLG4Em2UsyTb0PJkwWWgW2IKmvxhAbAcGdkvDU9a6KEoRHVld5eeXb1OPiy6k53Ee4Q06s2R7m4L1tNBlb7vpZZIYjmiBNyZqiuB44XuPAQEvGQ==)).

Scoring summary (recap)
- Technology Adoption: 18/25 — multiple site and corporate deployments (PPAs, solar, cogeneration, RO, EV fleet, efficiency funds), but scaling to full global operations still in progress ([corporate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGh8qe6dB8FgMHB6LxV-th1gy8FZ9F5jiNYUy4IUQR3ud7AG7OONmqdYUbeQ3QbOwQFWm3vlf9FDzrFjoJr-kiZJrdW4qIk7dFVqReMSLjqeJh2_nTktiIXoJrroJONkV190olB_j_jpg==), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvwq8-hjjRhkRD3Pdk2h75QTEE0Ol4KLoblL3lAvlZkWT-RU_vVebJJsztQ5LW1yRJeI6aW2zV5b6dyHzHWCYSXZtGdNvWJVyVs9MQVDPcPlrlsxGQ8LtkmH0ltzd0qNUiMS6dU6TDbbYJia8RKOagU_vovjgQNkxXwn2p1QdVIa0drVYIYZicKCTi), [abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEoNd8X8j7TviC6XtpHri4wG9ruSNtSzZwqqRrS0Qb4GpG8NTXt2tm0jz9Ky6cTScVGz6ST8k_XR3DvHdTq6M6upgmUW_SKIWmpMCQ-JMIMk3uMIolL30eu4Sp4zh1hBD9aCBqoZBESaLovZKtLTjmQBAtJlfItqSztAdoPgPtexpbf6GQgyvKFlv_j8jOZy_UOAOCXo9iljsONnnfeFfieIz41x6cPfS4Ed0r)).  
- Innovation Leadership: 17/25 — proprietary and partnership R&D (mechanochemistry, ARCH, sustainability patents), meaningful investment and pilots, though not the single industry tech leader ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHWctL4KLwhWLXFdEmsCvner426_ZT5IE5vrjErfSW2Vba-f5P9iJmbgD9EGH9w3OgXDNZqg8JCjG6U7ew5U0gTbSw7oghyAH_8Uf2-8mCXBTFDNnGEmPyqdgCMOmRjmqq8mViHQabgzvGKtNl5g1o6HKSYdm0W63hbAEV0-igS9XkysQ-pkfnkqpY=), [pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHw-K8rvpgYTONbSPZLZjNHzeZOb6JreY8YqelXzowZ11XjDBNbNt28ZkCEU0IezPIkeyKbebo0F4cnCXImUSa2MHmr3LbnEV4NlMFhzXkd50x_dhOY6rK6EwyZI1Xu8-aJySTA2_JoAMymwzEAN-mWv4zbz3ceOWL31rICtBELVGDlJTorPlD1tnyTMsgPM6LhQ_dETlFHa_r0TtOYgNJF2nBhlq1XzIGa0aKPyKFvELZJaHkzY4c=)).  
- Measurable Impact: 18/25 — documented >32% Scope 1 & 2 reductions vs 2021, renewable sourcing >60% (2024), waste/water reductions, but some project‑level metrics remain limited ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqYnUN2uOUpjSU2IgJ7JZbysQSrpk2FA0KSlyQsugvlB5zLrVpM0qUCMua_ujp5-GSZD32STcESi0JBJajsl87qIpteQ-DCWYkzfch2DIWF6pnNbREYntPexaxlVCIqdzBYZsmpL_8VXpS1QAHLK--2HYsG7qln-J9IaEr4bABKP7Wef-1ogpIS_UK), [abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGgiFpBqPOtaDr0qZ41nUL2AAhYkAsTCxfuG9XVq8tMGmpj7XGTmsQzyWq3S5ButB-0x7FF9RlKIjKflm6fX3aiJCZzl0NAIn6igYLpEoVPo48DwcgRFvQEkPHCvFdmruW4ct7nzcnN1GuRZgybUERMLh_8AkwBnfKSnBMwMcO8wd-s9FP3NVbHXljLAariQrYE)).  
- Future Strategy: 12/15 — clear targets (SBTi‑validated near‑term), funding and governance; Scope 3 roadmap/disclosure incomplete vs top scorers ([abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqcYfLroCIlX9rLkFtQqnc8QAyAD6zoCxnig7gLeJs5hax6O_k8O496d92xfB5_lyistz1hjI5nd_b9URQ_KQvekkhWKZjdKKM6IF9Skv3vkRrIivlxIpJZJwphp1A85xFz8lrGN63TRP8L_s_6ZvwiClWSW5zePSJuEhGwfVyA0efMkdAt0Yy5uDpego=), [net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEETLVwl2jen1tiPQFDk4H8EgyeUZscNS70J5fqsntRsdjpvaCSGZxf8s6EZI4kJn9hHO3M3d6cFCDmbkkGrmRKUsN9UZdB8Qhx-ODNmyIS640irCLpBQDzs6KjAGO0Vpsu4SJpGtSksmK1fEy4o7ujTQ==)).  
- Industry Position: 7/10 — above average and competitive; some peers (Novartis, Roche, J&J) have earlier/more aggressive timelines in certain areas ([novartis](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEldleJvCx3Cf679ezUqP4mZiFAyAGN0WBZHyRNi9mbB_MZQz58iPN-An8quOCjZAbBqIjCNWSqX3YvoA4zQlJBDSSA4dwcfHl2J-ii7sPQ5r_lptV8YSjmo3HuLvAgO197GPJeOJllt3MQpeoI-h0_gJf1MLB2VNolFvju9ShaTgvw40nb-_PrX87_kr21FebDVZGNL9E=), [roche](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWv5JlZHJBotqesVxWch0GMHTilMNUUSXurmdBYqxlV6IqKLO3BhJ4lTmQLG4Em2UsyTb0PJkwWWgW2IKmvxhAbAcGdkvDU9a6KEoRHVld5eeXb1OPiy6k53Ee4Q06s2R7m4L1tNBlb7vpZZIYjmiBNyZqiuB44XuPAQEvGQ==), [jnj](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF6EJOwIjtwR0J4tsIwR_wahVWMNOJCl08I0EK-5jxfLm_kfPGapgUwPq69rWuPZ1UNUBXih_VjEly-pgr0KuJUu2oDuhIP8H1P0RGFT9SLC2vV0NtKiOvX_xJnXBKtqtwHZ3_H-ygAXa2EgNwKkngSu2If8iyJn69oZpOiU5FMKHJ0CYyP94wAPA2glEhn8D5IGWhYPuW8IH716cLkmmtndzG0SZs=)).

Overall assessment (one paragraph)
AbbVie is a strong, active adopter of sustainable technologies with measurable progress and a clear, resourced roadmap. Its strength is pragmatic execution — deploying PPAs and on‑site renewables, funding dozens of energy/water/waste projects, piloting sustainable chemistry approaches and using AI to optimize processes — and backing these with SBTi‑validated targets and governance. AbbVie sits in the upper tier of pharma on sustainable‑technology adoption and impact, but to be a sector leader it needs faster Scope 3 action, more granular project‑level disclosures (MWh, tCO2e avoided per project), and continued scaling of its most innovative process chemistries across manufacture.

Primary evidence and references used (sources from the summaries)
[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2iRdA46l5adv1N5ngf5je1VkqSozn9fEbJQC-boaJadOBFVMNsvIUc4Ql5E2uclBKoNnKbkEJo6tVDVImP7CjYjlO6ZeNiS_E_z8VINQvQ4F1V0kL8QUd2s257CJ-B3j3uL0NOXtANRFlAusLnowkEfAQkv23)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF6JjFSIpWKyolBVBPGnSMyemaHkk4foDeUWuymfXmsZzKh4ckeeW6ws2NmAzXWMHdQzZoiMI3cKB09e0t-Kw0hWVKSU3r3d_O0Gsqoo9vBp6BTeCQGfv17hGPFH2gTN5Hyv8PSno_0D4G0XeW7FPXHfez9wdSXEy7WbwF0OAt-_L6JQB5co-Fd_6-XxcOwl7zSveOowE-TPsQDSFFqfUXRSDT6mfm_)  
[net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF5pgH6QSunxYgYdU5f3-IuRwZRb_j9oTq2I616Akru0I-qWD4sW3lPjA2W-zFKmL1Wmnt5ExWNUq7KPSTbEPp68YStUCR5VnL86ycnk37HIGcnlSq59JAaR5xGqbtvK-H9X4rTdEJYDbgc1Un56ZdfBg==)  
[ditchcarbon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1vRsdMJWrHB0z-RfbvyATzHSRRDaWifX4Al3U4r8YBpIGT0W4XG0PI-NgwIGttI7Ff-6M-zfDBxqx3RcCiOdpdYT9daqIeqTvvWxeGf_vJlsjRzP_20Njhckdw2JwYumkp96bF2bX)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFZO8zqMOVVMKNmFEcJ7CWUOjSraw0MUK3_24Uq1kPtdxEcEpQ54j71VzkyJ8XPIVCzdnSuhVm2GrJJDbzIxlMF9kwcTt5FNv1LVky29N9XJ-lE6biDCVPDbMuLUOI4-UMiAReSgr6tg798ppraV_xW2CVi9nPvV-ppRor4BuFIsck_6ScZPUXkzgPaLGU=)  
[greenawards](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG-7F1U2-_VCvo6lrSc7_o9ledh71ELMLS9p84GL7KNfDV7heRdYNeZFDzuoKYODqOVKp4ALK-yMh-_6T2DdwMPHIPTXnN5bTHEIXVTghdxVMNSdbBeHKF4r030k3PLo3XoGwNEq5fijdNOqmi62SxOZaham8D0DtWQ1RR5CxlJVuF3Q5A3wwibyLvFOpYAeDvvNSO9AL1EbqdeGpjBK2aC8haOsZAn)  
[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGLL_XDNkZsoTcBVZ00Q-vBD7gNXxPhOZMfTXoi9Wm7D2kObHXHs8sYZXLPNU6m7kXoSWtVJxlvdfqQtYpY5issRA3rErzPAQ1IFhlSRgq_4FJRDF8LCxNPw7gclbWxFU0AxqQkbyQyZBu0m06kiJi2C-HvIFVWn33w-HehNEV1fiuBkJuMZyvKKS5PikCjSjfX)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHli5nGHgY5KuFCfqWyWRHm374N0yPDL3CF3GxPIV-vGW11mLVVmq2p_t0lu_gMVyOpNIbbKyiFFqUP8qkmeGCmYg7SoWo5xFAGX5Autucku5hNLLDMlURwBfcDItSBDbAG4KjaaHi2Ab8ibcRMmPZwudJr57wCpkc6jEDLKTE29CPZCa_Y1ig75mz10k2t4pJxgJ9gNRD7DonYuFeswt1PjrFWC06k1rD9eKyK)  
[youtube](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEO0KqdYQTz0CdFDYBurtpPjP3wxHoWUvRHLBgvtcFIx6OtsYOU0bfk6F61SuMhvPaCd9J8j_D9qxzeJi6Vh6i9mBbSu5ly2JzkRDZe1AumU-H5dZo6mvUod77vQETEIWl0Ladz7fM=)  
[newsismybusiness](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFSzHNYDNwXllNAYJrz68x5oQ5XAi9RpXEX917AVdeRFJ5cX7IiOviCAPNfQ04pTOlTkPCZz7m9-fIENHYAYL_55jRVq2kpIXT9tWzX6GMwMWvJwYSoL6P77myqDnJP-rJl0_HZN8jnZ8t5FxvdwkP7YK2XJOcVbjln3UTV-8wujeTC04ulFp1KChFYwBGAwYXfGzEIjtQdtrtqkQ==)  
[investing](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHG9JSLE7C2rhh-VuF5ngG8apzeEdVLff2Z-k0uWlNe_AxTvdHCAuRFN8bxQFpXKopyzC1xutb3SIqNzrmqys85JK54yVMBWavvzsydzRATOVLoZNgzM3bYQTgCDZ6MWaNlVOThVYPFg0aJKHg4npqoxadNsDYB3rsPuI1bTieiMH9DT0BkCdHjfFOMqtnaKnzddz6XI64G3kQc9V98mUX_YqdKFl1bx3eY9jMAZtWm2wlARWqtqIFQEA==)  
[pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGX8-7635M7pXUG6_d10K3eEYqyghEHLrnlH5wIo-tReg38UMabFQ9wgX75blzuAohG6YElfGvzk1jgwbUnKrh_mrFim3h6xxcQcwcozofCDoVb34Y_NTXJ7BM3L3x1AZmHSZwW0EMCAg-aHHTKd9tJiKbUIdfDQ_DQmXo9F2TVLC0hZQ4XazMETftGtSUj)  
[stocktitan](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH27BDzwA5LRXvkqZ5id6mcAKEjtclbozZ4LwBNvNXYZuFR4G7_8ojHB3OC1v_sS0zSqofIx_mxL24Walxgo4kNuMUi-ryBz3IMXZGcq8zEi1YnUNECDhGmcl2kiE4laZFTuRXsClSibF6T_Wx5qqs88cQ-OJ-nues--8JLyze69KZlEN_X6-DKx3HDDE349V43NPfOy3qLNo8x)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEnHwa0oDww2iN4Gi551EIC-idsBFjVdN-eRUEGYqPhjN6z3YhpjweZt3Ia28yfdm2u4O0dz6hyvXpH4lcn6v-O7GOun7dpSCo7BP-sZa-ZPhTD7FiZWsAt6ZuCaZkvhoOZHTmSmvGJbA-HoDtIA5re6IFOkxy8QOEEKDdKPRd16Bf74QYb6mLQPwE6)  

[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGgiFpBqPOtaDr0qZ41nUL2AAhYkAsTCxfuG9XVq8tMGmpj7XGTmsQzyWq3S5ButB-0x7FF9RlKIjKflm6fX3aiJCZzl0NAIn6igYLpEoVPo48DwcgRFvQEkPHCvFdmruW4ct7nzcnN1GuRZgybUERMLh_8AkwBnfKSnBMwMcO8wd-s9FP3NVbHXljLAariQrYE)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqYnUN2uOUpjSU2IgJ7JZbysQSrpk2FA0KSlyQsugvlB5zLrVpM0qUCMua_ujp5-GSZD32STcESi0JBJajsl87qIpteQ-DCWYkzfch2DIWF6pnNbREYntPexaxlVCIqdzBYZsmpL_8VXpS1QAHLK--2HYsG7qln-J9IaEr4bABKP7Wef-1ogpIS_UK)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHYkhE_gO02ZKVYxS9S6KrIgDZNz3QouObNJsK9TsCs6JWz_tprQ2tLqVWHqq96cI-HOFWlFOrkODkXJuxHx9nsXqBa_E1ESF4PgzUkonR5MsV2pJC68_AKefE_OBGs56bxgRHSc_Z72lvYuiaZ2_yrApJWzFauCqEiP3EIYfLVEGQJD0lC_IJXZALLgXxKdW5Y7kT0M0eMRb_gFNtrYbKKAn5YpBkN)  
[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFnOZjCq9BP4DGHIiwrD-_MbUYCQ_-kQqWhL0otjeezwIlggA9cIThumKT4ATj76EleAH03Dk7dGRmdQhseo58CE7WVuaFXz-2zXaizA7FoJwB0UYd1uVjH6joDz5mlB9RYNmV-HYzfg5QiXoBFtCQnoKvLfqiS)  
[net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH-a-5eAXxykvraltUar4Cz2t3gomUcUmdPG76kNOfo0NaXn0Uy_TGNGB7KhGutXKKRNEkrVMiS_5NKi87yD2Lbv4BAXSXEUhI8dutrAEKqcOkVjJb3fk0aFlEpokG8MNBr-OXdfI8ImvlRAvCZCVYKRQ==)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqPGAq7PT9sMpmmRdyIUhmNm91299yQ-qGeO3Q0eNRfhbiURJWiOYZZAgd-pvQYhTSZ5cQda0GPMoXlq8nV4OQVfiwGaiM9bLvWkY74luAhH3nS9-uMWtpeYHRiVlns7rwSx8ko4Fko-4h2RBw2CESz7JLixZBiIMP32AKoOfbdzJbqDq272LeTA==)  

[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEI90v2thEvrQD2_uM2pYWsm1-b990HeHVuWOfUMvsva0Wa_x-AzKgZeB_kjy5nlp6gGCQ9kq8R-PzqNu3VCjkQ7eGfOAG3Wrp9C7cAkFLbfaEkhF9B8O6s6HD2ezPajIbDnRsoC82hcSBq5uNhbMh7U2toPuI=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFW9oii5iZL5ZO5mo0UbUEBHqr798Ojvtcupz8OgK7f4m2sQtOOs8g9I6TudbITk9Tc1VnFFMyu0IH2Nyyq63oBsxUS_aeGN8lWGBeNXgq_6ZqgWlOG7o-BhHe3kIDuVtYtn_qOOqQuVtMK3O1GFKkGVY-fMgD68PqjRSphEP4N2IAlSN1z6XD5)  
[knowesg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGSBHeNPa1q_2dMQM8vgzobWg7KksEQKDcgN5ZiKlgFo8_-CS_gVFVkwvQ9GBIjp7Z4wIbEFs1DPNcCZJFAyztTNEGfv6xRQTdpaZ1kUGDxcqQcSrjby3GsXoiZ83fQC2TMOwHBpamvrA==)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGut7sMYU8wVMzjVzOw04nTf-UM7PLrMNCIUi6qZGZ1qdK78CrJ2BVxMy-bL5md6egr_MDFMjNxn6Etv6UnjZ0sUs6KUhfzCy9TaX90mEGzCXMzTz0yd1xqQ1viOwPSJUwAva7gn07BEEr96HBSYD-eyN2V48P5lRdE_LuIJyn3aaU7CAa67k6M5Pf90pqm4UOuQuPfDmgl254TWUGvhfsdZvIfpPU=)  
[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtS58--rX8esfsVejKR7UCKWMwQBsmibPYrE2qzjealK1DnuT-UwODUFwGkUV_CFZanibEaKlyIASDVuF7KbxMtPUF9Tk2WUHNDdT3O56Ksq3kvgXJbZ9r29NF9pTwwQdbbMb-Hjfj2onCeFGaTQ2oPjdZxoVcXJQhixHyJ-LMfuyvZSVvAgYtndJKESFp_ZU=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFr3s1vJAjNaaJf5NmIxixIKkOSuSg20roYgq0RwF7e_kTaQVIdVydA_nVa2LPNyWLDp32I8j98bW1-OvoaQo1pH1eZsBHEgmWFYSQJLOOf0nqXdlbOsDOcOT5U15XtJslvEAPsLsWIshIiI0Ui3N69GlrjMCTZaFSAxwIyqmNE_c5F8njnkSqYyfU=)  
[responsibilityreports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHY6HA0HxGvhNMsHToisT2-SAIPVlXqLPrvC6J7QWJF6cM0QOkUa2NQcGkpbOaTri6H1q9Uu4lNX6ivsw2A_KR3C7zucwY49xsHfc7CxwH2HoKsuiI17DJwQDYboIkiAPMqFnAvMvhRx7FSyBvnxBEuiWndVbwvTgiO46fZ74aeO__xmkKlk8XEzOawkOrkqj6WXPa96yIP2_YCkg==)  

[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF_4aHn90BiV8OTHh27zh88w6mZEm9vZBHNXhN6cYGOM1i6NYIJJuSCUkJiChf2aoago4Pu2YKykxCbuFAV32-gZH_41PNcEN05KgOdFCq-vCiCk2XHpKEDegFgnNjIn3ZuirhCJs6eCFeLl7u6nWlFs4H6ukrkjAeY7TJ1Z7-WdrUPjuv6BnvOdoa-bng=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE8VNDjrlv2JYKMmx_vZpbR859sXNFBiekgj3-yvaLgVx3rOCNY8hUH-RNSSlbadR47m_1lFgV17CC-vrkztMSL3oNRaDAL8bu3aZa1RfaTMTxGjDvg8yMPgBIP77OdxnXBSH0Yn7eGAld5FjYx-1ZpuSRDOKzzWvrXKM7F3SSQvMRIANMVaa3fFeMZcBqbw06l-bXZlnibJ8UbO_eID7n5UGOP9yFC)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGfOJcmwagDtRCWMEOJHPxXxBO_yVPhPtW5jm5qyqJJnGauD-sJC6vt90vxFfUIQQcfVjznwxG0s6AbnPXcQw3tHlkoPU9gn_h21d30L6m9w9eK42CA3EkiCE6LE2x9RJSm)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGvwq8-hjjRhkRD3Pdk2h75QTEE0Ol4KLoblL3lAvlZkWT-RU_vVebJJsztQ5LW1yRJeI6aW2zV5b6dyHzHWCYSXZtGdNvWJVyVs9MQVDPcPlrlsxGQ8LtkmH0ltzd0qNUiMS6dU6TDbbYJia8RKOagU_vovjgQNkxXwn2p1QdVIa0drVYIYZicKCTi)  
[irishtimes](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFTuaqZpa727v1RyDYZ4xayNi8w2iBkez7WLjqkn-BOmdW31YxA9lTJgBEjvGQiDlaVNvs601G6F6GeUHyvvD8rtbBGakQHH8AABhJJN0OhoceIr3luR7AFpipPdHnB4nG9UkcGcSqBjj9dzRN13oD6fOwkntECil9gVWmFYly5novt12D5lrxjPce9TJ_ndeYwlCfJaEeDbdb45ao3Iggqn3fWCO4217VakEYlUyDn-9YchqncEmH5Vc8NRA==)  
[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHjFD6NAQ3bgiRz8M1rxlI5MsgAMq9c2T-4GL49M0VLOxzLcdnQFF3Niz1Nr62jMuLu6ItExdMgtmSUBEQvb2J1fgUogNtUCPyTCsZ0aKHZRhXyjgtYVRUvH8sP-mwoAYQS3kkprmfcooIudmFE22-QCgltK4i5)  
[corporate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGh8qe6dB8FgMHB6LxV-th1gy8FZ9F5jiNYUy4IUQR3ud7AG7OONmqdYUbeQ3QbOwQFWm3vlf9FDzrFjoJr-kiZJrdW4qIk7dFVqReMSLjqeJh2_nTktiIXoJrroJONkV190olB_j_jpg==)  
[mja](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHtG39l1FI6DPVI68bQdMw0q9D4F44n24dbP2JTtbtelVdb0yu-3SBu6YWq1fGj6XY_9iskQ-IboqNaLmN-zq6aQ833lrGQsTb4zN7rKuTht7L5YU3xPbJh_0WqRdrVs6T8YpS4xDF8bjUmHZqTJpnKP-atsZv7XOYlAnNI181WhXdHRd6ylKyJ0jZcp2TLNBg8Wg==)  
[prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHArLQZroYRa7_J_dYFt8-VmB0OqJ3ZiIfGZCoUi_0cZQibyooIQ0LbqR8LOjDMP30dcs8DI0Xv8zA8hE1tXh8JK49FH1iVzO9vGawNOXNYm3DKjDoQhOyJ6_-9FuF5LHJY7Yz8TftT5vj-d_CDkhct-kVkVun09Fgq85AF5rA8KnnRgKHfmxQgqhkjRaIw99qAVS67QJuNhPT_WVsRrB65AlRKbzGSIw==)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGDoGQvrl2nN2N9KJt04CAJtfsgR2OsJHAT94jRUrCIs_MH-D1UQap43eQCp8ySw9VwDV3q5RVs52hECbajyOM3M6zpzUskbdDB87t585VQIR_X3iy4XhnPpu_aW2brn4pv-EEHQyuqVNVD-CNRYqNKQjHAG-v0b6YcNEr_FUcBbs-SXVQ8fHPNrQ==)  
[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHwRsO9IAu-4ssBrE9JN9Oc9f3hvzitMBMFN3cALU4Iv3g3AxpOFnQdVLJ1NTWa7Pq3j7y4vk-ODemYxvh0J5A0Mcsvf88sGxC9aYLWcMt86tDFSBd9Plbh8ViIBHESftWI8jQVaAoZ6To5zLDrNqr5_Vzasj20cz6e89sO_I-_cllC8NFcj5n-NjWScUgMaVUm)  
[responsibilityreports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHxxBf3QFTgIbtLlvW1IODvL0gFDMsctaVrqomLkaWDBWk6rny-o34LmEL-1-ArdiMjWYeJVxmruaFMrfiYosiBQ6RkDTm0Cc5lIZewvbBm00kox5j6CBYZWexsu6sAznju_Ni08YgUy4_uhBX3N0qFVfmFlsAn2p9jZv_82P8GJQ1xl479rqPXw3tssHoyPTBuHoKKf3J7D73Dzok=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEk-x_-Z_DiTq3hOhut9EL_0pm6j2pVd8X5KxHY8IhL4a78yvdWqICn-BCO-1F6fdclMa-nSeAVKWQpVi7OSmDTrIkP5T2hHpw0VgM9VTHtSIV7Jg==)  
[prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEY_gtzZsnjrrQcDZ2L704K4R6s196-oJVoOKY4stKHttSytedE28k-x9cqcxGtU2Vge9ghr1Tb583FtKA_iC78jNkwzohOTwvnmTZpTncuntxlqSbV4dgZVaHdasAQI1k2twNWYoHMgOCZTZqjOsN3gfGX-_UpouUI0xDqcM45SP4thxJ2pT7uTQeco18ENkryg1eUTyjcivPtVHSBmkertrGbTKLHh9QZlk03l1R4CSrbCJIMnj6LAEsKsvKln4nWCl3tCVY18WouEEISlpMzIIZQmhO9EkXAs8WDcwo=)  

[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHy9s9mpsinLHpQFFz1goScDDcXTBlCzDa1l5UbYvuVsHeuEJXQTYFL06lW_lu0-jDz2mpjIpERMERcqltWFtpnKAWPWfeBzvLgmH50h1Bvr5g4C9aTS_zUFjBjMqM1odT6RpjxFfPr8IrULw2wsaP2Ubdiq4nepSw5ESj74QlGwdsvJ83A1wxULQ==)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFz8urvFvTkqCtaSDMbmXpPTq9YIFNuthl_-EiH2E7KN9Ph03cvVNounp3N3WY9Uq7zQakiNF_j0raKlUdocEUR1YZO_S0rU5_SFMXjiUnAvGB9pN8YgM23u5uwvpnI5mOA8UlydI0CKvOMRl3OJd8c9n3GafOQbbhCL1KHgynuurSROkE-k2I2cyFn)  
[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFibUgwMeHsGgbrzi2fu--1l59TO-8XAkDcx-saL-gn26Mh4Lo9HiCqdMHXp-n-g3pzRfFbTr6S1g2Rs0_-rO6tBU70FK7G3Ep3-PQg7CafEoPnG3IuSFC41bZsRIiSbQtl_BIKVthmok3KF0ndPW1F4Dp1n3lD)  
[responsibilityreports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHawZaCkB72r0MVbMV_jcF-7BQ6_IoWxbgzl0t_QcVNXT4emOt8sJE0GG8WguNj8-TKg0bp6_ikvXepo7tH_2sovhEQfMd73BXaCdba5-7bnxiOuRInP66hP0ugEhaPN0Wxk9oeZqQ16jEz0OdtyJCQJMfY298i8Q_XN3OuhQ2qy0GjBCM1LgfSFr5jJY9IviZuGPHlqQblS9GEWSs=)  
[prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE_eE9yep0nDlmDgOsJLa-zKbF5_iWoxYk2I-e9PtQ_MjFlj4tOXR-o9xG0HKvSfmhGiCs2Hs_wJ-LLQu1ivfHqxzyVW94WZupLc5mYOIr_e38xRr6sd2v4pHGzfr0oZGaPJa3I_7zK9yeXqGLCdF-UY1q44fOqxTO8dkIsnrF4QE79kGZImAn83pTVq8AOFYTeqRRKfylyXvU24LsYm3bez-EJcO_cQXsO-a9FgM99x-C7qX88CDRc7E5ixqaj6Q==)  
[investingnews](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmL2GzDjxFDhE0aPSScY9JhEJhg3BdjlpCr6cSJcoz4I11NU3RqmJyeaItCavry5ERB85_ZJaX9Hzh9ohiDnhYnd_l_ZF2NQg43RfvNWkaIBlEJzigJZz_L3b5hsBNtNQYmWm9fz5XkzngMJ9Oi3KC0PkNN-WHhckP_kI5TTTyshjr_0g-ydZJXAgYk4GoEKWhuBr7_sO6c-lGUgHJU7BhYw==)  
[ditchcarbon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH2tLwERcPahTaB_djAmYp7zdQ-jRzTDrNpp1MAarE2Jo0P3cgbfeOjgS8HtwSsT-nkDJyAtpRHnF_yZWBtDC9kC33LDv_uZkcL7NVdwP0zU9zV1e7qQpC6So-dWq5hCSl_QF41EZS5)  
[csrwindo](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGtZ-Gm4zOy_1xDsg2Ry6C24mKRyQS8PnLMQ5sJqsN1iqtvdpfalwhWK7AvniTrlYpDixA7oOxQv5aqEj3BPo7WUMPGAI0IBxMmKDidmeczLUqZ9g5FXTQjrk07lKNhs3sQv7-aZMvIolfRdXWoRr7YdP6PMlyoI9BDN-hui4m7AtABRQWumYGJ4u1t-wfmW0Ym43t9)  
[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEs5Zzondot3_horhn8YxqNqQrgrRy6NVFg5gtCGzFSl-WGk61Ww6A6R1P2J5pj7s2XtZXJSnUw9-bwYhtdBD6UUWodMIq88Wq4JjWbMyxtIeOH8oY5qukG_YDTMAAqUDm1DSAn0z0_EVneY3kLP1aJMMH80UruMBlKJD4vjP_f-Y5WGOaqVAVV2hsDepaCH09Q)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGpiNYoB7y07U1iO9UyYYO1rj_sgAfDMTb0TH_X82NMKPgA4rUnZa7Ycfs0e5Ncxe2hOE8k1cCBfmWcIW2XxoKH1NiS3bqTSUI3WGDBCFPPo3uQvvBgOPTPNyKaD1HYOZJZ-wHHcPxKunQExLQBuIfhQ4KSTyum_N66hhWCYZjqrQ3kOeniI5eWpego2H7mETlQoLXskJ0YYCkCERJcyon1baQRZLsN)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEoNd8X8j7TviC6XtpHri4wG9ruSNtSzZwqqRrS0Qb4GpG8NTXt2tm0jz9Ky6cTScVGz6ST8k_XR3DvHdTq6M6upgmUW_SKIWmpMCQ-JMIMk3uMIolL30eu4Sp4zh1hBD9aCBqoZBESaLovZKtLTjmQBAtJlfItqSztAdoPgPtexpbf6GQgyvKFlv_j8jOZy_UOAOCXo9iljsONnnfeFfieIz41x6cPfS4Ed0r)  
[atomfair](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE2cM-xt5GopxR3kfPnZNSZGGZSdWgrmkbFsrn6IdT8gosqICS253fS0uHGZ01n1Amg7O5b5BIFThL902zjFf-MRUHdVXaazFw5urHalbxJUkP-jbE4D6ISGhJoTIx0SjMWQlQbQkRerPuJAwQ=)  
[researchgate](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHa_P_NzzHTZLeHnFsEB8CIXHhOVG2zcY9yCo3mYxA1rejnGcpHYKpt7CuO759DF7NTuxHScd78ZuQ4E3KH3-83eMb4LchszcBrO3rkmoyAJYc--PtY0hv6tNus3sRTTmz9ZtsjhBBkqo88uchQg4ALdAw3ciOCP8VWvWh_bplqxx7Q7IS41p2cE9mHS3ArJPhEr0xgHtcshnw1a_mRP_P7rvQTUO99GXg9ZgHUm3JYo9UZKgGhpNg7aGUWffpYcg-PSOQoqCq_l36Xn-5kwX0CAbw-6PYH5-8eHhjZ6M8=)  
[acumenstories](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHgR_PuyxPmWxors7Qpt0QR9qxivBJVd9k9LWnCvVuVbEtBjuNRlck11U8HQe8AAO24xGnoqCbCiFskUWz4La8cZhoKcX1VN2FINB-surqb13GstseHPFLmqqpoymSqwDtZoNs-23yStGaBrWQtMmcur_stZKlkGOoEVwE_UprWhVfeQKQrP7wJXyTHd3kKPJAil4KWGm5rBlLl0HrohhQkbJA87FLcCpU=)  
[aiexpert](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEX9ZlXb3NEVxMNw3DoSNz9W8DVOAR-d_dLW2k368gmxsLY-s6u0QWIkgonwaGLO3oftfeV5SEw8VolAClxhrKUGpnzuqXVbPripVYhHSgm_WiOvI2yvaPNjy_eUOCd4ToxCqIF14C9FNCS4ZhSyFlFV6zq86HsHplpvkaFFr1BGSQS7g9l95V6iRkqERSpG9QX)  
[youtube](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFGF3OntThaARCf32TLrhy62oeaTrFroR7ScfLjHVdGO8Lb3_stXtIELHoaO1PbqaDLvKkvH9llPJYVFqWstgg6HxOvRaB2tpRAMPEJbwhKQZxQ64zluUn8UOHJ2AFMZdbDXRssjCc=)  
[pitchgrade](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE3CPVXzsg7y8lIUm9CWdI1F8plfl4s05sJFK-b_tSlnGKZDCVjt7sERwPiUJWcp3FN1a7845LbGohHRsmV2R1CcEp3KVd5kPKP3OqcLcfwM3AYpppffPSjW5R1TxPgkvrbcc7g6msnmE_jTwlczCU=)  
[industryintel](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8I8QezCJU-tvL6Il9ofCpXEqqGf9Ig020ie2V2CPXG_3kJaOEpsSGx90uUCoGIUn8JEGM1LWxfG6cjjRdX3x08MxqTZubi8gQfgcnpzOwE_qatACoOUxMorvt3_bM22fP6rra-avT-hSmEfwfHUZADlBbjguEQvhsV8P-iC6DTadlGtB-N7M7fqJTPwJg3sxlPxFLf3ZwuIrEFKopKHA2KO9VayK7wmUJONFiK5B51e9u0BVx2whwdXAyjorwx9nhb9PqaTrVV7o9DOS8infFaiUEbCoJfzK3lNQZiQ5Q_ycAL1jEuhgGwVjogXBgRWtBo3rwOQTQ3g3k25WJKaq-lk5VdCJr_XPz41MJ1pAmRX5pYy0vN6Dv2wSqBEXsNNMyezlRXv9GyYmdKCCFx6MHhnh2eDTOesaEBQ03PjfALm1VhqCp6hSUYhU=)  
[pharmalive](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGEFfNXIauaLQZssAmohTLhjl8No8Uoht0C1sBHYqCvyfS3ryfRB7sevtCucR4JxAr8esN41wMcFp4pvZtGKbXk_WNfUHn14kJKG_zO5Akkhr-6cWE1JH0N7us1wg06bB3z3iZpyCKk82ThsRp5oHmNhgaXK7zubhjKm333Zb8OzxsuMvHR8BhhwAul0AU0JYlHAd0I1Q==)  
[pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHw-K8rvpgYTONbSPZLZjNHzeZOb6JreY8YqelXzowZ11XjDBNbNt28ZkCEU0IezPIkeyKbebo0F4cnCXImUSa2MHmr3LbnEV4NlMFhzXkd50x_dhOY6rK6EwyZI1Xu8-aJySTA2_JoAMymwzEAN-mWv4zbz3ceOWL31rICtBELVGDlJTorPlD1tnyTMsgPM6LhQ_dETlFHa_r0TtOYgNJF2nBhlq1XzIGa0aKPyKFvELZJaHkzY4c=)  

[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHA0EaW2I3EuDt10nVD3N4GFDP2iN0y0h-d-5ZfNPH82LKTGVDWnFpNauRLq-54c2pEJ8lbab72gUUWNxRCjq8K0g2DsthN3YZVN7RIIilgfunewE1WXrlle68JcNDKQETbKZaHhImD3j0jTmRiLbBxmT-TC7Q=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHk6zjVru_2j3vKVY0os1QzjsWLuptUJujcLLranL1UfSEx54Kf32lQcpgEXX3RA44L1jI6E8HTGwkw5Z6JtoanezodXsZRf6f8St_kG-XKFJGcDlXUw45JoqEZ_a9vGTwbwVPmRUoLp_z95UKhp_-yEOGvAkOZSEGdmaU0HFsDsCJdrJlyrEwITPnZgy13Vw==)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF_GaV_wiMavqSqlW4RrbuSCJybLyIvwco77J32zDngSgG5luVmLUhZPdsmGwyafbE1ZWoPL-Et3bTj1HRmMy-ZEnI1x4F6rDK08BLU7kyGQUQrNm3pw3ysoO2bRnDT9_bS09O2_xZ3uhSwu7OMo1H9OJrGvNT2yuRJLEkpj-DJV1fSFEH_0SchXE4GXQZl-g2O0P-rJdmhl27OdwcvGRuJsHnRrjU=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEXSDs3kV7G2BBCpx1420IMUmQzNpt-4iVjG1CBNAKvgdqHI3tKOFetkaSr1Nim7Em-r_OGqB_9I2ZoOkLChL2xUCf2qaN1VDWs6TH4OsWBXM_A-lgqDlqmjz6aBpry_zC500mE6yYRqbKKKZMEw9ktDVOt8DhXsR8WXn0SMM1bYLz3BoCFUZS1L1d2lOYDw7wrzaJuEwQ2Rk5jP2zgUI6Fq23Jox9raZqlBidAujLTulvECPBpeWM=)  
[ditchcarbon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFp9b__RlvvBJfAQEZUqUCmr06x8fIzUXfj2e5W11zRJwS3rrbCYZD8DERNfO99gh2zZLe3lvqqgX2paHRrZQvwxPXEuKKWh0jvoprCD6LYXJu8tZDB7qzqXz6pUnrJ_fdeZJKMYLk=)  
[irishtimes](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHSbQXWLheS4EfZBK8kyKL36TKHB7PHS1K7teEckgn1NSsWyZ6LaNHMEkdB3TJ_gFrlhbUwtXLI-YKOALrh00UDhZZAEgYTObHSvMseEogOFpNQrXmuIp5FNb-GM26emKCJw_ehbxBALRaMYrOSSk279wDVNCC0iz3IutWHjjlJW_lXooX1h3IbvGVc3nyh8CgfeiFA-h9MbejQFsuQU2e7owehhvy8Wdh9XnDZDX2EOPSiSX1f8G5jMJyM)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFY534s_Cx5-9ikizpU9Gv5aZWf_eSHU7hlnbNPIhgDs_7s-kKabHmd74GjCrp1zhOariBJACZLsLjlOuGgUnNS8U2aDiN8E57_iGfmX4vrEeO8yC3T-WMNE6qc2KOYXM4=)  
[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFYQTenVNwqHjChmcLEWN8edjt49Wgru71VxJXRXHsivrKhwZCRelOnXutw46eX_x3fCjRTW_7Xwpzdg1iJ3zWUhCWgQll8uzHLDLnxC2HoJtdTNeUkjDRXs1NT-MA5MLQ-8l9owbgCu3mEBfC-mvd9P0LR8yWZxYVsn2IkxRbV_Ul183r9W5RvHON-ffRz8=)  
[bandlondon](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFoF2lzzMXn_EW5Q_mWBABxs1J-7ji0192wb3OW2tlnWJRv3vEX_S6VIj2IV-RV9GDu_FpqUwuuUSbHUGTeZudbtDoWtvJsAa1Jz0mljzH41LDPNNyJg6uvr9_zNas-HI4omf8P9eO1-OU0xSbidPtsZz53lx1xp1bqxRt_kdN78_2PhUNulrH8GQ==)  
[epa](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEpxlAm1cFLIbFNuiyCEmUN2yNIE3bgsVAWJkisDuuXahT9FUitMpCmrr74etcQiZ4rVFUIuDYLPddDglrys-BitjxhaNKiN1naKk1jkyzOzT6ohA3Y51C6JEdi7d-m0tpcNGLYTi8j8lA4Z0beUFX9kuJru0Aad0DbZursAUZSZxpS68GC46tfi-m4Rizb5AA=)  
[iu](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGi24r99RbVk8rI6Bv-rlJwhFU3azV79a4O8VAtRKXBhGPAVPFEKrJGtKd8Q5BT3pzA4boGSBR3gVtKfnrXg8vwqwjPwhJG5JdxWbJ5o71FqPb1x_AQ1pGLaxB4MCGBMHWhTZkHNwOi0YVoJ99etxxtgrfwYImA2CRmlnZTAGe7Ku2V6ZGcwSjPeqDakYH7t4sjBHY-Ew72gzB8QAEdj1s=)  
[kwrwater](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGA54wqDcf-RgCQkFL4XZAVVYiZxPZccbjKgVH8sgOYSldRf1RvLW658ngHRKt-oNOLBVAaLMXqO5VPtGM8l38vAi59_XGSjaW0TtpNql-aUE8OHngPPXpbRv3mx-cp-3jC90O7pa4pzDZthDskykGsj9oudifZnuaNmWsHVcXLJPTObVuj4qg5hqRC7UeuzxtY9-tI4JayHQqi9GBFb4AZ3aqrWXjuoKI7xXg_8ghaUWVvpEskBj4WCK2EQhmm3mQUt-HmH3vT_cMRflyZzagOzw92hI1gzcbLvGKK2fo2jDXgOmZdoGVUE9fnn00Xz7jT7tFVx5PcKHcE5Rc3pk58Y60=)  
[nih](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGZQRG2wCSmK_MbWeGAI68cq8QxkN6l6ar3AGMU_OTWVSBPMBUYyicIfCVdRBUdNXz5TqzkFDACOTFzeaJ8uJq9vqDVRtPea7vjztx2T8A1Egb3VrsBfNvpAHfTiXqJhZrW9McFBfsyQWoW-Q==)  
[verra](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFAmZ6j-M2iHSosKBH11RxdYoOvt50zAHKGEqUQA6pDezTlVCbP-zwHscem1P7NH_VT83CFtrvnCFOnkwViFIBXof7RRrT2pOyfFY78S6Vy2jEDv-_q8tSzmsrQPHODbdtma5F12VwGPdrfchxa99v6kcYl8NC1Y0hrc8yqEw==)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFKwk52S-x-cD4o7OVZX3qvkxzu8xiaODmje-Nen6NlW40bBEaaaK-Nubf1t_YA9tn_u69zInJJmovyID1ZU5ghOfxkAPBWL8KCW8hx6b1LNlnufbs8dAPd_Y-95qXi9gG0pxpD0fB5oOjvO1RUelqLNeDTO-6e62Rm0LQc5QNJafNyfqhWGY8ILFdEQl5717zfPvVdqr9bjA==)  
[worldbenchmarkingalliance](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF1nc-8IbydseMJPfqtKCvX_EIFb5DBqZCvrRUXiL195EdyyTyc7KTgLptb9AuCv1PFr_4_3gFH1p1CKLmzM0Spq05iYPmyjjLzurSuo5EbvA4HQaeebFObPo93r8U2Lyb31Vo-7LUVmsY8cvxhSSR57yRa-Bz07bQaKPO4usG6NVS548ksfvcY)  

[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF4sPYvcif8t6A4TZXpslUtiERCqC1PjslbEPlNhATwUCur37anIMONehBX4dce515RSqV5yqXXCZFB5q24bvlHzwV6IxK7X0ZTBxjxdUT5CIE5cTuMz-2VR90-SVBwIwxRpnL7PTaF0kGsqMavrXME2rMJa16I8OQGDbwgbnF55q7vQgRK3GTMa9T9RZU=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFhjuBZ8WyO2kagE-yN1P6GjayLrSaaph5o7cxKqiTRBAf1B3v-pb4fReXU62brZiCAtROOCKGGsxRe_7KHNIyLNxHlbLAI0X4J94yhY3H6ai-cdoKbPBa6Iaz7Girpc6xFt-inOSUgsXaKuR69ipjr0RKGHZTXQosY3D7UR_jjcl3oBy51tzb4PH0ZmwjsntKsFVCR1JthGsDMXx56ExBe42WXDzgp)  
[net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFOeou_7NWvlUcU-6LvQlDjkU7hiE6QVl7pmRs-IuTpsd39uzmoYQ7_mczvKcsje3RAsPYsJy5T6O5Qx_2PpFLVurfkzzpmR5F9C0VKwMZBP6QhMn3h2k228mU1P1XWAgWxtpKaZht7PpVQGQVl_a8LmQ==)  
[net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqilZPKW3hTgL6ae124-vwZrqKiYrWmQlfIV2wkzp2E6GwZg-30OB02jMH6NpZP6b6GpVgiG9lBP9JVY7bbYprxrmeuA-vFmenOy-rFfSjCINd6NWVUW43outEHtvLPRWlpQ_2GV-PwiJDTZdl7krRaXk6njhVbRIZQZv4TMkz8MBIwvR6e1Vh2f8SgfHLJGRNVhKz8z4nuQ==)  
[esgnews](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHJT_8hTyedux0GyCvjG8xWt8r_3aLm5PtAMxokN5vG-CrcCEmxfnV1pR1S1wvY5PxnZbh6aqhMiK8F26OFczAKmgMA27k_gy4mpXeveVmnMq6tfBm_3oV8y_nBWRyMubw8uZsPeZJMmwR-J5KUe3-8-gSEDeCeNoHOSpjUjNZ47M4E5_HHixAoGTVZtymn_9WXauPlx3e0i67FH-VJdS3-pwbWS22yrcnlzS_gsrE=)  
[healthcaremea](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFA4MhDT30T5k68uC7OCRaBABNNCS_xrLbuDHi5yTGQMxqUNqqEsWuZFGHX-yt0fOay8q5Cwws7QrFX0euk_FNGVoNOXhk41jBqUj8GAwfedCECmqJu8pHpPCAQlt5wJvpSkTU7hpawj03F5MN_HLXza2w56wsU-OaSpH5Lp4w3gzj4nI_WIbytiO-QVWYDEvvvRLjE6ghJ)  
[pfizer](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqXpJanJEUcXYeTN3fveg2XuZEKWQ7zTFtfC1D6WBXZ2-ZHeHrjyBU7IFRHXvAtvHPJPv16_dGyRIoJUgWcHYQ0gJ8rx_36ZEKoa2J87VwJM2BYvI9UaixnHhTs1eIIIvt44ALj72dmdmO4DhrDKfelVHg_i6mRV9mpeHgV4QSglGbR_ig308AXr9x-hcRtgSXEFOPKdF0bsEeWZEqAdwdn9QwHG3LlJI4FELR8FcwrtUXRiajGRF0bA==)  
[pfizer](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF8MBviFkxqGoq__gbDrhKnOZknhnqFBGsBnAdVAoqDCqkQYKdDKoy8OREtqEwooi91PVJ9cj6TNZVvdpHqh_Feehn_QY3beXIn8Tq-uiobMoeFI0mWgUjIQhb9i813mw6MTa3_pNEXhh1zUf3PD-U7btjZ0FkFwvPp-C3lG8HPUM-28gqQK_E03m8nPmwVK1Uie7CEY44Y5igruxyh1r27XvXXMKNfF-NtqXECeoud0g4=)  
[net0tracker](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFxjUfeS1PZkgs9OsMgkVTCJmHW5lg3Xbb4l3-OHwJsLs6CaUPZottOLd7aydK0VmHaJqT32EPqWYGSaYeWk8lrXmqjk_ZcqTnRLgtORY6mefYblxFm4CSun9tPFTCRDKJchYqECw-ucAOiXU67keDlsg==)  
[impakter](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEZxEzBOkUBVEd9gM-QDIDPeaU8zpy5ZHXqZqNeTYZ2RuxhD_aHiK6SbgxpB1BNjTsulISPlV5wnEfEUvexpToCp-vfJC6nxAEz0QquHLUBtklCQvJ6OU05p-BsUgNc6GyYPdkscUwkXJ8ZmliEJjCwViXa)  
[novartis](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH6WtawqdiN5fgfFWyssQaHzdKrc71BYgLe7aeqKztX6111zQWjTvFGNwH5MlwZJ7S0WPChrAWeoSzIoFRugJ4AyjF0Z9UnVor4ZU2iaWqxw_-zWMsrqyN_WiwBf96AEWirL97RusaktllN7lt4ImxWNwL1BsYXF-OBVmHh)  
[novartis](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEldleJvCx3Cf679ezUqP4mZiFAyAGN0WBZHyRNi9mbB_MZQz58iPN-An8quOCjZAbBqIjCNWSqX3YvoA4zQlJBDSSA4dwcfHl2J-ii7sPQ5r_lptV8YSjmo3HuLvAgO197GPJeOJllt3MQpeoI-h0_gJf1MLB2VNolFvju9ShaTgvw40nb-_PrX87_kr21FebDVZGNL9E=)  
[carboncredits](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFxTPEcCn2GufotLg6X1KOSZS7--1DkUclMJSn4ljqdyDMHXNKMthSiF3e9C7xi0ISEu-lhft4RAtfTDOTmHIGI9N-u1-grGIkhxsEooHoQHuLtVAdbSrcDLtZ42DtIVhXqX1jrUcK2_LvYAeCa5BUeGwpGSo8-2rqMBFcAtGybT4WFPkU0ZwQE_U-Y8G4-56HdSbnekeFH5Hfu6ynWLeY7Fj-_djfQsw==)  
[bio-focus](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvszX9ahvU41pDZUuRL3nI81fYb9PgZ0zALA5PpD039IT71YQa9-fwd_Pyk0rT8mfSkxbb4QwZ4CfHO7mpEnqhhCunmrTDPYBgvmIQ-_zqtXJlVZ6aeo6CqX5aTL-yA7RlGgJIsqn85P6DidXAzZxA0fdQ08Z9YTZnpvTLYlzqzv_0qviWEd_0JOAz8re3xZGcDwMJFkpVLnEp)  
[ispe](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFB7uhbxulJvLA3mEMxaWmc19itLh5eEJL-zL0SuAthfeM2vNxIKlQV6uB0FDhn330BCAwv68pOsLczN3-GVSgtHG2tgBvZmbzkbC-OyviK67Iq67NGpu2nI2qZ0j7uZ99a7oBU_fNt1JRB-_5Zvu1GTvnKTUSsUMLSFFqcjJB1ccO1DnBa9RX3SgKnbJAem4CZVbjXXwTU3H4KeLveDxY95RDMIA==)  
[jnj](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEqwxlHZUFCOVHyranOkS_n98BN3gGuYP-uGWRjhhjL0IScXvuMrWlbPdnahSCW3RJfbHDyfyqn7M-ooQb5X_Q5aZ18wG-Z06jY-apt2AakM-zGJzTH8q_mLiwZsZ4wOA4-eCuXUI84kOGhkKaIcMlPXudeHH_md9YkeA==)  
[jnj](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF6EJOwIjtwR0J4tsIwR_wahVWMNOJCl08I0EK-5jxfLm_kfPGapgUwPq69rWuPZ1UNUBXih_VjEly-pgr0KuJUu2oDuhIP8H1P0RGFT9SLC2vV0NtKiOvX_xJnXBKtqtwHZ3_H-ygAXa2EgNwKkngSu2If8iyJn69oZpOiU5FMKHJ0CYyP94wAPA2glEhn8D5IGWhYPuW8IH716cLkmmtndzG0SZs=)  
[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHS-lGZEQ1JEEKeOOaoY7EXqHnW4or9JrRnNu084Qu5-7UnuvkFHEbeE51zgjDJ7NG8hMzPqcaJsiSo_3wp4V__TaogX5vsv1sYEfjVavcFnejfIqcpUivX_oeYGE2__XRwVjIeoXWzY3lyGfnf7L7G)  
[sustainabilitymag](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFFhkoTBnomVsaNmT3mfOzvj41nphZ84LQCC748MxXPqS3dZxK5IGEXAlVDhN1Kw8KHN-JkU5WA0QQnmqVnfV8NX7-DhsQvpit1jD0Blc8D2NGarE7dGzbG7s1OPcBTWYcZ8FoDCI2dWRiYN8zQdHNFSPKSzugH_aQHJ7AEWVGsxBXDGn_iaskzOSafXX5WekdBzwg=)  
[jnj](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHvWR_m94YRh_-YYJAZVjK7DCMabYAuFiBluCVxRh7JUVLJeHMWPrzP2RBpemUzKaIYXHrJJAqjW-SPFEk53N7CifYId2gEMQFD_vyhlHZbWT8A7wgkT7D0ULzcPPwgEjIZdn0q1begJiTpRhJwdL2TMEm_6paZoQ8BUFeJ5oUeG5nDFVCORTZtt5Fr672MAvEfa9fufitL6dGiCeplhW6wIB8RxMfXCKO9tfT4g9dZ9DhpJrsWzCG00rR7OsBWhe8ABsLxK8XgfTk=)  
[roche](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEWv5JlZHJBotqesVxWch0GMHTilMNUUSXurmdBYqxlV6IqKLO3BhJ4lTmQLG4Em2UsyTb0PJkwWWgW2IKmvxhAbAcGdkvDU9a6KEoRHVld5eeXb1OPiy6k53Ee4Q06s2R7m4L1tNBlb7vpZZIYjmiBNyZqiuB44XuPAQEvGQ==)  
[smartenergydecisions](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFmiPk0kcQIh38bQD2AnbpPJS6MYOXnNtPpQew0S6yU14TSQMnANHOoRO9BYpsg3kmriBHLy7CsNF66vjItwh57V9BsPKmcU06sfC3JxksJBF7mVaXd9GfOWe6pCjpRxRvy3RBCX8-C9A6-1jdyI-BWVS4aQfb5jf2sIrMyQ7qtsoGwVn06CTOaGYzfHjF_)  
[roche](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQECdTP3REqpCnLA-Mthd9OJ5fMmvrBOAFsP7HNAhbEVcw7yRlj9LZr0nAg6Y-UV89xbmnXObC_2wP7NfTHVPdoWSSll6Mh9lCMZf4zTYg2Dq72otkeX2hXnYeh7muBlIoEfnT_egWTgcc_6dj1CHYScBG6RiITt90g=)  
[esgnews](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEsxKH8_jiF04bjpi5MGhKD6EYAY8HxxENvzti4vk6Vzed7vLorM9JxDwQFSuHg71OdRQAjTD7eDhQZawKfIIOb9KYXMSOOcdzrvDPgAaLOj2BI0oeteL88bFRasEwtmIFcOa4C5ELzHxz2W_LYD-Tb48XXppMEtptvQ7SWI-RutGDqxob67x1wVMe9YMVteLdW85EhqJJSYwKY9t5WCLKkACXi-gJpnD-zfc8PgM2OaA==)  
[esgtoday](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGknAJZBP447fFRW2BhAvQiPdRLD3q8nW4MnYsOg40bri7ZyzWtOsihaRcAfP1HIs3DXWjzpGf6JULjt8hFZqx6Qs6k5YeGnLqglJwWjaubjRmdhaZVtogitTwPEop6sgQV3dnpnntBJNmcuhF5orutucFhk5HjgHHDfZamlWE=)  
[pharmafocusamerica](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGlZq7w1RXMeOLtOlP2jwT3-j_clc3Li5muCxHLfucbzm6ntF_mzs1pcN0vmTTLA0LCMrYLrUFvQHb1SlS5p22iKnrZ-LkEdN-VV1NF9h3AHuiD0Q56RlfgtBLfn2YbD1KuazSau91INAWD6Ng_gdoQBv6QOGtPSlkGJ3Qkz6hZQ8bOxAxashlC1fsfrnqXN-JWEb9-Dg==)  

[thesustainableinnovation](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH7kJyVHh80VZWVcE-FzgtDK7UJzbnuwZ3geDYjGIc8--1nNFpl9hLzVjnnde2A6FTz0cRO3LmGteR3VKDj_I2dCZYJKd6KmC3o2d_trqZhzXXkSa1xP1RcRA4cGM5qFspyqE5k6v6XHtoTeqMgiLTsshkl9A76)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEX-mhNyI1ANOtYl0kZLCfF_zpqelUHMJkrN27pFvHjux3D--BuheacbhPDey7LJnHF-DJ0CQrCGSVBRqcAJX5MZVdU-S3tsrKEkSpsWudBF6OLZ6-xfXybbdCK1rI0Fyu7YigciMVwPPbxDM9xOPbHTg0DoJTGlguRT1cv87Iu1xC2oflSqiJ1a2Ick4MwI1MI79x_mU4=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGqcYfLroCIlX9rLkFtQqnc8QAyAD6zoCxnig7gLeJs5hax6O_k8O496d92xfB5_lyistz1hjI5nd_b9URQ_KQvekkhWKZjdKKM6IF9Skv3vkRrIivlxIpJZJwphp1A85xFz8lrGN63TRP8L_s_6ZvwiClWSW5zePSJuEhGwfVyA0efMkdAt0Yy5uDpego=)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEJZmWGFpB4PXjslTUpZRXW_vyy5Yn0Cr8NzCSOObiIonQUkCnzafmN1LpGIWpfLAFfgV0CzPXzgVbi1YGgL2nXjf5bkJ5zFcq8tbqvTR7ibc1BffmtOD9bQIpbwjK0qB2OXbwgKUEhAGQhrWeycv_5DxOK6NkzHCGABa7bbf4m-yyrOr44KLQyYyKOfHNAgGsPK1zo4d95tv4Gkr-LghLC8fkRSyBJ)  
[abbviecontractmfg](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2pnoKBVxZd7Y1o2fZ0o7LTpqDQcP72LzXpwU48VGBdclCA5xEPnoy88WNluHfKu_ubXBEqTuSVzt0NkzOkocr1ULoEiOGlxA8i7RgAjCjOsievHzKRltJWDaUHoA1lEjuxsS8BrdW2F05Op8EHUdx0502fJau_-xhqtP-LfKmJqXEZjbJrwvEgtELxMsX9Bst)  
[abbvie](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG-IJo6ujNd_d1UTVdN-vX6_3z2PsEa5EWhzdZj4o9fCuB1cDWp46L91L2OEfxljox-yYHt3DN0C8Vv8nqYvnX3OGUTWT9dwgx4lUJ2HQqHktRnCbajRmbchOwR6GS5XV-tjfaR5dyvlydAeH0afc524sKQmdulx0EKmYQhx0Mt4mohMtdwjp8jU-yo)  
[businessplus](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQETEaumN6zKjQeqWfz4umExiHQSW42AYXguh5XJQzHzT9TGrsmmxZnktIiDMP1AWh39j1MRn13JnqYMwEBF2toy2jFcHoZdxyjMWy0At96MsA6FOfkc2PoDx0KW7_EeGDL1WfvPRsX-gZ33)  
[responsibilityreports](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHK9SvrYsd5zKUvnJNYePMGi2AkUATctgoex-VE6FLa69IIJCSP7hcukFC-OR-rUXedFgQEcsIbndtgDH9HaZmX39GjMLOOWxlk97K4gzysTOxy7lI4aX4HkmhYxU7ysY1iL78BELUpTkKo0g9rX4i9j6z99WUZ6BO56dAzkmSMJOwGO0UAA99kDfoCjb8oq2qZHmOTtMWuF-sHsTk=)  
[pharmaceutical-technology](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGubfe-j4sIaJHtd13Yj_Gd3O-ItwREMQOu-wb_XcoT-nH4qOrwZRvVxYBa-pwiJH3QFN_ujvrMuV98Cyu55_yEvGBaQ-eLNf00aB3JoM3IrpFCf0Y_HahHQeF77RlBBGKesLpgv_Oyvn9YIe1vEwjQv7xKoopPiG6ecbBpcUV9pXqTEOdXCu2iqx3CHMTf)  
[serrarigroup](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGp5tp9cCIE7bwk9zVcKbe8MKxg5-nKqL5l0GO8wLWs6oA9wO4oO_sF5JZdBhTVeF7q3hQXA3HLl_kFbBuydtJmWjbtQzADCRSiSNQryZnCFsdY3Wg2jRmiOPwymQn_b9zr79RVCcdOgQ5YybwXtQZSniFL6AFIuPhxOAUKF9646cX0bGKaKq8seKxpHgW-yiZ2)  
[prnewswire](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFYbrEcV-jqiR1JqLYQvRUX90uRaXWByGnU9_cl6RxPuaPGsZlDVYfwcMKGZh6t86dCRFp-PHxEAmx4TqVCI4qwGs3IAZS6bW1PQOWnNXKv3Wrd1lO6viPlfuAGUe7RcQot_ggtS88T_hIxEqypNxmPOqTArbqZ2yTKawnLg1gbjfT675nW09NlAPkPDDua4FHilo2cuLSQYC_2ufFIhWN1NqTY1kmGjIluS8BFIIJFwvsMRhS7oO9lRYto7Y67RZQnW4tybHqGHis0X1ceHavwOd1vN2GfJMBqwEVRung=)  
[constructiondive](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGoGNczNb2ECiiehmN5qUzoaqmofPOZA9JVJphaObpcXzQMFDtwi7SfkX7_8ZUWfjARH7XIzrFOlF6BwtO4NyfW2ujJvEwgUWwRg00QA3GJghjXq9zMQ8ULstPfQt1tTFDGJRfs-RVKDCNRt_ljqNFfe20UOeA4_NOX1nkgYl3qSNzEPwKSJhOK_Rk49OGMQE230gDvLite3C2lxX8M)

If you’d like, I can:
- produce a short slide deck (3–5 slides) summarizing these findings and the score, or  
- drill into one technology area (e.g., mechanochemistry, PPAs, or ARCH/AI) and assemble a more detailed project‑level impact table (requested MWh / tCO2e estimates and source mapping) using AbbVie’s public reports and press releases. Which would be most useful?